Pith. sign in

REVIEW 5 minor 234 references

Toward Ultra-fast Treatments: Large Energy Acceptance Beam Delivery Systems and Opportunities for Proton Beam Therapy

T0 review · 0 major / 5 minor · reviewed 2026-08-03 · deepseek-v4-flash

Pith's one-line read Widening beamline energy acceptance would remove the slowest step in proton therapy and unlock ultra-fast delivery.

desk verdict A genuinely useful review of large energy acceptance beam delivery for proton therapy, but the clinical-benefit framing runs ahead of the evidence and the beam-quality gap is real, though honestly acknowledged. read the letter →

arxiv 2601.13577 v1 pith:MZKWGFLP submitted 2026-01-20 physics.med-ph physics.acc-ph

classification physics.med-phphysics.acc-ph
keywords protonbeamtherapychargedparticledeliverylargeenergyacceptancerapidnovelmodalitiescompactfacilitieslayerswitchingtime
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

Proton beam therapy is slowed by the energy layer switching time — the wait while magnets re-tune before each new depth layer. The paper argues this bottleneck is a design choice, not a law of physics: conventional beamlines accept only about 0.5–1% momentum spread, so every energy change forces a full magnet re-ramp. If the beamline were built to accept a wide energy band at fixed magnet settings, switching time could drop by orders of magnitude, enabling ultra-fast delivery. The authors survey a decade of large-energy-acceptance beamline designs and argue that the clinical payoff — shorter treatments, less motion-induced dose error, practical rescanning, and future arc and FLASH therapy — follows directly from this one change.

What carries the argument

The central object is the large energy acceptance (LEA) beamline: a beam transport and delivery system whose momentum acceptance spans tens of percent rather than the conventional ~0.5–1%. The key identity is the relationship between beamline momentum acceptance and the energy layer switching time: when acceptance is small, every change in beam energy requires synchronous re-ramping of all magnets to a new field setting; when acceptance is large, a fixed magnet setting transports a wide range of energies, so the ELST collapses toward the mechanical speed of the degrader and the control-system latency. The paper frames the design requirements as geometric achromaticity (all momenta converge a

What would settle it

Measure the delivered spot size and shape in a prototype large-energy-acceptance beamline across the full 70–230 MeV range at clinical intensity and scanning angles; if distortion or energy-dependent variation exceeds the ±10% size / ±1 mm position tolerances cited in the paper, the claimed treatment-quality and motion-mitigation advantages would fail to materialize.

Watch

Extended reading notes

Core claim

The paper's central claim is that the energy layer switching time — the wait between successive depth layers during pencil beam scanning — is a fundamental constraint imposed by the narrow momentum acceptance (about 0.5–1%) of current beam delivery systems, and that this constraint can be removed by designing beamlines with a large energy acceptance (tens of percent). With a large-energy-acceptance beamline, magnets no longer need to be re-ramped for each energy layer, because a single magnet setting transports the full energy range; only a degrader or accelerator setting must change. The authors argue this eliminates the dominant component of beam delivery time, leading to ultra-fast delive

Load-bearing premise

The entire clinical case rests on a large-energy-acceptance beamline delivering circular, stable, energy-independent spots across the full therapeutic energy range within clinical tolerances; the paper itself flags that most proposals suffer nonlinear beam distortion and energy-dependent spot variation, so if that assumed beam quality is not met, the dosimetric benefits evaporate.

Editorial extensions

If this is right

  • If a LEA beamline is realized, the energy layer switching time could drop from hundreds of milliseconds or seconds to near the physical limits of the degrader and interlocks, reducing total beam delivery time by the 70–90% share that ELST currently contributes.
  • Ultra-fast delivery would make volumetric rescanning practical, allowing many repaints per breathing cycle and better averaging of respiratory motion.
  • Bidirectional energy delivery becomes possible without hysteresis re-ramping, enabling new planning optimizations and facilitating proton arc therapy and beam tracking.
  • Bragg-peak FLASH delivery, which requires whole-field irradiation within about a second, becomes feasible with a LEA beamline, whereas current ELSTs preclude it.
  • Shorter treatments reduce intrafraction motion, permit smaller planning margins, and increase patient throughput, directly improving treatment quality and cost-effectiveness.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • The review's logic implies that the accelerator choice (cyclotron versus synchrotron) becomes less decisive for treatment speed; the beamline becomes the rate-limiting component, so future R&D should shift from accelerator design to beamline acceptance and magnet technology.
  • A concrete testable prediction follows: if a clinical LEA beamline is built, measured spot-size energy dependence will need to stay within clinical tolerances across the full energy range; if it does not, plan quality and robustness will degrade and the dosimetric advantage over a well-tuned conventional system will shrink.
  • The paper's emphasis on transporting a large range of energies rather than a large energy spread suggests that LEA systems will still need energy-selection or collimation to control distal fall-off when the degrader produces a broad spectrum; without it, off-nominal energies could distort the depth-dose distribution.
  • If the technology matures, the cost model of proton therapy could shift: single-room facilities with a LEA beamline and a simpler accelerator may approach the size and cost of a conventional linac bunker, potentially making proton therapy a mainstream radiotherapy option rather than a specialized one.
Share X Bluesky LinkedIn Reddit HN

Signed reviews

No signed human review yet.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

0 major / 5 minor

Summary. This review article argues that the energy layer switching time (ELST) remains a major bottleneck in proton beam therapy (PBT), and that a beam delivery system (BDS) designed with a large energy/momentum acceptance could minimize or eliminate this bottleneck, enabling 'ultra-fast' delivery. The paper reviews clinical motivations (shorter treatments, reduced motion/degradation, improved rescanning, volumetric rescanning, bidirectional delivery, arc therapy, FLASH), surveys proposed LEA beamline designs (Keil, Fenning, Wan, Brouwer, Nesteruk, GaToroid, Trbojevic, Dascalu/Sheehy, Liao, TURBO), compares their geometric and optical achromaticity, discusses magnet technologies, and examines clinical implementation issues, particularly beam quality. It is a review rather than original research; its claims are supported by cited literature, and it explicitly identifies open challenges and the lack of constructed LEA systems.

Significance. If the LEA concept is realized, it could transform PBT delivery by removing a recognized technological bottleneck and enabling emerging delivery modalities. The review is timely, comprehensive, and technically informed, providing a clear distinction between geometric and optical achromaticity and a useful comparison table. It is appropriately cautious: it repeatedly notes that no LEA BDS has been built, that most designs suffer from nonlinear-field beam distortion, and that very little exists in the literature on LEA-specific planning/dosimetric impact (Section 4.1). The paper also correctly states that full exploitation of a LEA BDS requires an accelerator capable of rapid energy variation. While the clinical benefits are contingent on solving beam-quality and dosimetric-modeling challenges, the review does not overclaim; it frames these as open problems. The manuscript is a valuable resource for the field and a credible case for further R&D.

minor comments (5)
  1. [3.1.2] In the paragraph on Keil et al., the phrase 'the drifts appear appear much shorter than the magnets' contains a duplicated word ('appear appear'). Please revise.
  2. [Affiliation] Affiliation 6 contains a typographical error: 'T echnology' should read 'Technology'.
  3. [Table 2 / Reference [168]] Reference [168] is cited as a dataset. If the beamline parameters (1.23-2.32 Tm, 70-230 MeV) are drawn from a peer-reviewed publication, please cite that source instead or in addition to the dataset.
  4. [Figure 10 caption] The caption states 'Figures pending copyright permissions.' For a published review, permissions must be secured before publication; please ensure that all copyrighted figures are reproduced with explicit permission, consistent with the statement in the caption of Figure 2.
  5. [4.1.1] The sentence 'A LEA BDS which does not need to rely successive magnetic field changes for each IES on may offer better stability' contains a grammatical error. Suggested revision: '...does not need to rely on successive magnetic field changes for each IES may offer better stability...'.

Circularity Check

0 steps flagged · score 1.0 of 10

Review-style paper; central LEA argument rests on external evidence, not on self-citation or fitted predictions.

full rationale

This is a narrative review, not a derivation with fitted parameters. The central causal chain — ELST is a bottleneck; increasing beamline momentum acceptance avoids per-layer magnet ramping; faster delivery yields clinical benefits — is supported by external measurements and planning studies (e.g., refs 38, 39, 41, 97, 98), not by the authors' own prior results. The self-citations that appear (Yap 2021 for the ELST bottleneck; Dascalu and Sheehy 2021, Steinberg et al. 2024, Yap et al. 2023 for LEA designs) are descriptive or corroborative rather than load-bearing: the ELST bottleneck is independently evidenced by Suzuki et al. and Shen et al., and the LEA proposals are reviewed as literature rather than invoked as proof of clinical benefit. No equation is fitted and then renamed a prediction; no uniqueness theorem is imported from the authors' own work; no ansatz is smuggled in via citation. The paper explicitly acknowledges open questions, e.g., 'very little currently exists in literature' on LEA-specific planning/dosimetric impact, and Section 4.1 candidly discusses beam distortion and quality uncertainties. These are honest limitations, not circular reasoning. The only mild self-referential element is citing the authors' own earlier review for the recognized ELST bottleneck, but because that claim is multiply supported externally, it does not constitute circularity. Overall the review is self-contained in its argumentation and appropriately defers to external benchmarks.

Assumptions & free parameters 1 free parameters · 3 assumptions · 1 invented entities

The paper's central claim rests on domain assumptions about the importance of ELST and the feasibility of LEA beamlines; it introduces no new free parameters or entities. Its evidence base is the cited literature.

free parameters (1)
  • None
    Review paper; no free parameters are fitted. ELST values in Table 1 are literature-reported measurements, not fitted by this paper.
assumptions (3)
  • domain assumption ELST is a dominant contributor to total beam delivery time
    The entire motivation rests on this. The paper cites clinic-modeling studies (Suzuki 2016, Shen 2017) showing 70-90% contribution; if those models are wrong, the centrality of the LEA case weakens.
  • domain assumption A LEA BDS can be realized while maintaining clinically acceptable beam quality
    Section 4.1 explicitly acknowledges beam distortion and spot variation as open challenges for most LEA designs. The clinical benefits assume this can be solved, but the paper itself lists it as an unsolved issue.
  • domain assumption Published LEA design studies are sufficiently credible indicators of feasibility
    The survey of LEA proposals takes their simulated lattice designs at face value; several have not undergone detailed error/fringe-field studies (e.g., Trbojevic 2021).
invented entities (1)
  • Large energy acceptance (LEA) BDS concept
    purpose: Central concept: a beam delivery system accepting a wide momentum range without retuning magnets, to eliminate ELST.
    The concept is an engineering design goal, not a new physical entity. It has no falsifiable handle beyond the various simulations cited (none built clinically).

how reviews work

0 comments
Cite this review

Pith. "Pith review of Toward Ultra-fast Treatments: Large Energy Acceptance Beam Delivery Systems and Opportunities for Proton Beam Therapy." pith.science (2026). https://pith.science/paper/MZKWGFLP

@misc{pith2026260113577,
  author       = {Pith},
  title        = {Pith review of: Toward Ultra-fast Treatments: Large Energy Acceptance Beam Delivery Systems and Opportunities for Proton Beam Therapy},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/MZKWGFLP}},
  note         = {Machine review of arXiv:2601.13577}
}
read the original abstract

Treatment delivery is largely determined by capabilities of the beam delivery system (BDS), where faster delivery can have many potential benefits including improved dosimetric quality, utility, cost effectiveness, patient throughput and comfort. Despite significant developments in accelerators, delivery methodologies, dose optimisation and more, the energy layer switching time (ELST) is still a persisting limitation in existing BDS. The ELST can contribute significantly to beam delivery time (BDT) and extend treatment times, requiring compensation by optimisation planning approaches, motion mitigation strategies, or active beam modification. This fundamental constraint can be addressed by increasing the narrow energy acceptance range of conventional beamlines to minimise the ELST, enabling ultra-fast delivery. A large energy acceptance (LEA) BDS has the potential to revolutionise PBT through immediate improvements to current treatment delivery and emerging delivery modalities: the complete exploitation of PBT - and unlocking its full potential - can only be made possible with advances in beam delivery technologies. We review the abundant opportunities offered by an ultra-fast BDS: shorter treatment times, reduced motion induced dose degradation, improved effectiveness of motion management techniques, possibilities for volumetric rescanning, bidirectional delivery, further planning optimisation, and novel delivery strategies. We overview the design concepts of several LEA proposals, technology requirements, and also discuss the remaining challenges and considerations with realising a LEA BDS in practice. There are multiple avenues requiring further development and study, however the clinical potential and benefits of this enabling technology are clear: ultra-fast delivery offers both immediate and future improvements to PBT treatments.

Figures

Figures reproduced from arXiv: 2601.13577 by the authors.

Figure 1
Figure 1. Worldwide PBT and carbon ion beam therapy (CIBT) facilities: operational, anticipated (under construction) and proposed (planned), total number of CPT facilities listed above bars. PTCOG data updated Dec 2025 (5). Single room PBT facilities are those reported with one beam or gantry – including dedicated ocular and upright centers. compared to ∼USD $100-200M (13, 14) for a multi-room facility – the standard route in… view at source ↗
Figure 2
Figure 2. Compact, single-room PBT systems with gantries (left) and upright systems (middle, right). Hitachi (9), P-Cure and MedAustron synchrotron solutions (top). ProNova and Mevion upright solutions with the Leo Cancer Care Marie chair (bottom, right). Images reproduced with permission, P-cure, ProNova Solutions and Mevion Medical Systems, pending permission from MedAustron. beam momentum range bypasses restrictions impose… view at source ↗
Figure 3
Figure 3. Schematic showing typical PBS delivery. 3D coverage of the treatment volume is achieved by scanning the beam across a layer (in the X–Y plane) in a predetermined pattern before the energy is lowered reaching a shorter depth (in Z), then scanned across and repeated again for each consecutive layer. Adapted from (17). The resulting dose distribution is highly configurable: delivery parameters can in principle be varie… view at source ↗
Figures from the paper (9 more)
Figure 4
Figure 4. Figure 4: Beams with a narrow (0.05%, top left) and wide (3.5%, bottom left) incident energy spread (ES) and their resulting spread out BPs (right). A shallower surface dose and sharper distal fall-off can be achieved with a smaller beam energy spread. Reproduced with permission…
Figure 5
Figure 5. Figure 5: Magnet ramping sequence (shown for rescanning), conventionally from high to low energies, adapted from (66). Schematic of a hysteresis loop showing the field current correlation for an electromagnet. Stable delivery follows the cycle from maximum to minimum energy when…
Figure 6
Figure 6. Figure 6: Dose distributions for a stationary target (left) and with motion applied (right), modelled on natural breathing, axes in mm. Resulting inhomogeneities and hot spots are shown when considering a liver case (top) or a 4 cm diameter spherical target (bottom) in a moving …
Figure 7
Figure 7. Figure 7: Delivery optimised for a simulated 4DCT plan accounting for breathing motion during tumour tracking for a momentum acceptance range within a realistic treatment band (left) and without limitation (right), adapted from (98). The number of energy layers is not typically …
Figure 8
Figure 8. Figure 8: Energy meandering scheme showing ramping profile for both ‘up’ and ‘down’ sides of the hysteresis loop (see also [PITH_FULL_IMAGE:figures/full_fig_p014_8.png]
Figure 9
Figure 9. Figure 9: Schematic showing components which may typically comprise an ESS (left), adapted from (153). Beam energies are reduced after passing through the degrader, resulting in particles with a spread of momenta (right). The ESS aperture indicates the distribution of particles …
Figure 10
Figure 10. Figure 10: Rendering of two curved CCT dipole layers (left) and photo of the fabricated mandrel assembly (right). Figures pending copyright permissions. This is a provisional file, not the final typeset article 22 [PITH_FULL_IMAGE:figures/full_fig_p022_10.png]
Figure 11
Figure 11. Figure 11: Calculated increases in beam size using the same nozzle geometry for various proton energies (left), also showing the effect of reducing the drift distance in air by 40 cm (red) (198). Measured spot sizes (FWHM) at isocentre in air, at different PBT facilities (right)…
Figure 12
Figure 12. Figure 12: Upright static arc delivery with TBs (left), adapted from (227). Illustration showing the arrangement of transmission (‘shoot through’) beams to irradiate small spots at the target boundary with larger, conventional BP spots for the remainder of the volume (right) (23…

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

234 extracted references · 158 canonical work pages

  1. [1]

    Physics and biomedical challenges.Nature Reviews Physics 0123456789(2021)

    Durante M, Debus J, Loeffler JS. Physics and biomedical challenges.Nature Reviews Physics 0123456789(2021). doi:10.1038/s42254-021-00368-5

  2. [2]

    The role of radiotherapy in cancer treatment: Estimating optimal utilization from a review of evidence-based clinical guidelines.Cancer104 (2005) 1129–1137

    Delaney G, Jacob S, Featherstone C, Barton M. The role of radiotherapy in cancer treatment: Estimating optimal utilization from a review of evidence-based clinical guidelines.Cancer104 (2005) 1129–1137. doi:10.1002/cncr.21324

  3. [3]

    Estimating the demand for radiotherapy from the evidence: A review of changes from 2003 to 2012.Radiotherapy and Oncology112(2014) 140–144

    Barton MB, Jacob S, Shafiq J, Wong K, Thompson SR, Hanna TP, et al. Estimating the demand for radiotherapy from the evidence: A review of changes from 2003 to 2012.Radiotherapy and Oncology112(2014) 140–144. doi:10.1016/j.radonc.2014.03.024

  4. [4]

    Global democratisation of proton radiotherapy.The Lancet Oncology24(2023) e245–e254

    Yan S, Ngoma TA, Ngwa W, Bortfeld TR. Global democratisation of proton radiotherapy.The Lancet Oncology24(2023) e245–e254. doi:10.1016/S1470-2045(23)00184-5

  5. [5]

    Particle therapy facilities

    [Dataset] Particle Therapy Co-Operative Group (PTCOG). Particle therapy facilities. https://www.ptcog.site/index.php/facilities-in-operation-public (2025)

  6. [6]

    Radiotherapy and theranostics: A Lancet Oncology Commission.The Lancet Oncology25(2024) e545–e580

    Abdel-Wahab M, Giammarile F, Carrara M, Paez D, Hricak H, Ayati N, et al. Radiotherapy and theranostics: A Lancet Oncology Commission.The Lancet Oncology25(2024) e545–e580. doi:10.1016/S1470-2045(24)00407-8

  7. [7]

    Three ways to make proton therapy affordable.Nature549(2017) 451–453

    Bortfeld TR, Loeffler JS. Three ways to make proton therapy affordable.Nature549(2017) 451–453. doi:10.1038/549451a. Frontiers 27 Yap et al.Toward Ultra-fast PBT Treatments

  8. [8]

    Commissioning of the world’s first compact pencil-beam scanning proton therapy system.Journal of Applied Clinical Medical Physics19(2018) 94–105

    Pidikiti R, Patel BC, Maynard MR, Dugas JP, Syh J, Sahoo N, et al. Commissioning of the world’s first compact pencil-beam scanning proton therapy system.Journal of Applied Clinical Medical Physics19(2018) 94–105. doi:10.1002/acm2.12225

Show all 234 references
  1. [9]

    Hadron Therapy Achievements and Challenges: The CNAO Experience.Physics4(2022) 229–257

    Rossi S. Hadron Therapy Achievements and Challenges: The CNAO Experience.Physics4(2022) 229–257. doi:10.3390/physics4010017

  2. [10]

    Commissioning of a novel gantry-less proton therapy system.Frontiers in Oncology(2024)

    Feldman J, Pryanichnikov A, Achkienasi A, Polyansky I, Hillman Y , Raskin S, et al. Commissioning of a novel gantry-less proton therapy system.Frontiers in Oncology(2024)

  3. [11]

    Updated Status of Protom Synchrotrons for Radiation Therapy.Proceedings of the 27th Russian Particle Accelerator Conference(2021), vol

    Balakin V , Pryanichnikov A, Alexandrov V , Bazhan A, Belikhin M, Chashurin V , et al. Updated Status of Protom Synchrotrons for Radiation Therapy.Proceedings of the 27th Russian Particle Accelerator Conference(2021), vol. RuPAC2021, 4 pages, 0.468 MB. doi:10.18429/ JACOW-RUPA...

  4. [12]

    Proton Facility Economics: Single-Room Centers.Journal of the American College of Radiology15(2018) 1704–1708

    Kerstiens J, Johnstone GP, Johnstone PA. Proton Facility Economics: Single-Room Centers.Journal of the American College of Radiology15(2018) 1704–1708. doi:10.1016/j.jacr.2018.07.020

  5. [13]

    Proton Beam Therapy for the Treatment of Cancer in Children and Adults: A Health Technology Assessment

    Canadian Agency for Drugs and Technologies in Health (CADTH). Proton Beam Therapy for the Treatment of Cancer in Children and Adults: A Health Technology Assessment. CADTH HEALTH TECHNOLOGY ASSESSMENT no.145, Canadian Agency for Drugs and Technologies in Health (2017)

  6. [14]

    Inequality in Accessibility of Proton Therapy for Cancers and Its Economic Determinants: A Cross-Sectional Study.Frontiers in Oncology12(2022)

    Xia Z, Wang J, Xia J, Wang M, Cheng Z. Inequality in Accessibility of Proton Therapy for Cancers and Its Economic Determinants: A Cross-Sectional Study.Frontiers in Oncology12(2022). doi:10.3389/fonc.2022.876368

  7. [15]

    The societal impact of ion beam therapy.Zeitschrift fur Medizinische Physik(2020) 6–8

    Bortfeld TR, de Viana MF, Yan S. The societal impact of ion beam therapy.Zeitschrift fur Medizinische Physik(2020) 6–8. doi:10.1016/j.zemedi.2020.06.007

  8. [16]

    Retrofitting LINAC Vaults for Compact Proton Systems—Experiences Learned.IEEE Transactions on Radiation and Plasma Medical Sciences6(2022) 282–287

    Clasie BM, Bortfeld TR, Kooy HM, Seybolt K, Sharp GC, Winey B. Retrofitting LINAC Vaults for Compact Proton Systems—Experiences Learned.IEEE Transactions on Radiation and Plasma Medical Sciences6(2022) 282–287. doi:10.1109/TRPMS.2021.3083982

  9. [17]

    Future Developments in Charged Particle Therapy: Improving Beam Delivery for Efficiency and Efficacy.Frontiers in Oncology11(2021) 1–25

    Yap J, De Franco A, Sheehy S. Future Developments in Charged Particle Therapy: Improving Beam Delivery for Efficiency and Efficacy.Frontiers in Oncology11(2021) 1–25. doi:10.3389/fonc.2021. 780025

  10. [18]

    Roadmap: Proton therapy physics and biology.Physics in Medicine & Biology66(2021) 05RM01

    Paganetti H, Beltran C, Both S, Dong L, Flanz J, Furutani K, et al. Roadmap: Proton therapy physics and biology.Physics in Medicine & Biology66(2021) 05RM01. doi:10.1088/1361-6560/abcd16

  11. [19]

    Proton therapy delivery : What is needed in the next ten years ?British Journal of Radiology2019(2020)

    Schreuder AN, Shamblin J. Proton therapy delivery : What is needed in the next ten years ?British Journal of Radiology2019(2020)

  12. [20]

    Future Prospects for Particle Therapy Accelerators.Reviews of Accelerator Science and Technology10(2019) 49–92

    Myers S, Degiovanni A, Farr JB. Future Prospects for Particle Therapy Accelerators.Reviews of Accelerator Science and Technology10(2019) 49–92. doi:10.1142/s1793626819300056

  13. [21]

    Future technological developments in proton therapy - A predicted technological breakthrough.Cancer / Radiotherapie (2021)

    Vidal M, Moignier C, Patriarca A, Sotiropoulos M, Schneider T, Marzi LD. Future technological developments in proton therapy - A predicted technological breakthrough.Cancer / Radiotherapie (2021). doi:10.1016/j.canrad.2021.06.017

  14. [22]

    (The) future (of) synchrotrons for particle therapy.CERN Yellow Reports: School Proceedings1(2017) 293–307

    Flanz J. (The) future (of) synchrotrons for particle therapy.CERN Yellow Reports: School Proceedings1(2017) 293–307. doi:10.23730/CYRSP-2017-001.293

  15. [23]

    Proton therapy – Present and future.Advanced Drug Delivery Reviews109 (2017) 26–44

    Mohan R, Grosshans D. Proton therapy – Present and future.Advanced Drug Delivery Reviews109 (2017) 26–44. doi:10.1016/j.addr.2016.11.006

  16. [24]

    New horizons in particle therapy systems.Medical Physics45(2018) e953–e983

    Farr JB, Flanz JB, Gerbershagen A, Moyers MF. New horizons in particle therapy systems.Medical Physics45(2018) e953–e983. doi:10.1002/mp.13193. This is a provisional file, not the final typeset article28 Yap et al.Toward Ultra-fast PBT Treatments

  17. [25]

    Accelerators, Gantries, Magnets and Imaging Systems for Particle Beam Therapy: Recent Status and Prospects for Improvement.Frontiers in Oncology11 (2022) 1–20

    Collings EW, Lu L, Gupta N, Sumption MD. Accelerators, Gantries, Magnets and Imaging Systems for Particle Beam Therapy: Recent Status and Prospects for Improvement.Frontiers in Oncology11 (2022) 1–20. doi:10.3389/fonc.2021.737837

  18. [26]

    Emerging technologies for cancer therapy using accelerated particles

    Graeff C, V olz L, Durante M. Emerging technologies for cancer therapy using accelerated particles. Progress in Particle and Nuclear Physics131(2023) 104046. doi:10.1016/j.ppnp.2023.104046

  19. [27]

    A review of proton therapy – Current status and future directions.Precision Radiation Oncology6(2022) 164–176

    Mohan R. A review of proton therapy – Current status and future directions.Precision Radiation Oncology6(2022) 164–176. doi:10.1002/pro6.1149

  20. [28]

    Zenklusen SM, Pedroni E, Meer D. A study on repainting strategies for treating moderately moving targets with proton pencil beam scanning at the new gantry 2 at PSI.Physics in Medicine and Biology 55(2010) 5103–5121. doi:10.1088/0031-9155/55/17/014

  21. [29]

    Review of technologies and procedures of clinical dosimetry for scanned ion beam radiotherapy.Physica Medica43(2017) 79–99

    Giordanengo S, Manganaro L, Vignati A. Review of technologies and procedures of clinical dosimetry for scanned ion beam radiotherapy.Physica Medica43(2017) 79–99. doi:10.1016/j.ejmp. 2017.10.013

  22. [30]

    van de Water TA, Lomax AJ, Bijl HP, Schilstra C, Hug EB, Langendijk JA. Using a Reduced Spot Size for Intensity-Modulated Proton Therapy Potentially Improves Salivary Gland-Sparing in Oropharyngeal Cancer.International Journal of Radiation Oncology*Biology*Physics82(2012) e313...

  23. [31]

    Effects of spot parameters in pencil beam scanning treatment planning.Medical Physics45(2018) 60–73

    Kraan AC, Depauw N, Clasie B, Giunta M, Madden T, Kooy HM. Effects of spot parameters in pencil beam scanning treatment planning.Medical Physics45(2018) 60–73. doi:10.1002/mp.12675

  24. [32]

    Cyclotron and linear accelerator generated scanning proton beams for lung cancer SBRT: Interplay effects and mitigations

    Liu CW, Kolano AM, Gray T, Stephans KL, Videtic GMM, Farr JB, et al. Cyclotron and linear accelerator generated scanning proton beams for lung cancer SBRT: Interplay effects and mitigations. Medical Physics(2024) mp.17082. doi:10.1002/mp.17082

  25. [33]

    Impact of varying planning parameters on proton pencil beam scanning dose distributions in four commercial treatment planning systems.Medical Physics46(2019) 1150–1162

    Alshaikhi J, Doolan PJ, D’Souza D, Holloway SM, Amos RA, Royle G. Impact of varying planning parameters on proton pencil beam scanning dose distributions in four commercial treatment planning systems.Medical Physics46(2019) 1150–1162. doi:10.1002/mp.13382

  26. [34]

    Energy spectrum control for modulated proton beams.Medical Physics36(2009) 2297–2308

    Hsi WC, Moyers MF, Nichiporov D, Anferov V , Wolanski M, Allgower CE, et al. Energy spectrum control for modulated proton beams.Medical Physics36(2009) 2297–2308. doi:10.1118/1.3132422

  27. [35]

    Geant4 simulations of proton beam transport through a carbon or beryllium degrader and following a beam line.Physics in Medicine and Biology54(2009) 5831–5846

    Van Goethem MJ, Van Der Meer R, Reist HW, Schippers JM. Geant4 simulations of proton beam transport through a carbon or beryllium degrader and following a beam line.Physics in Medicine and Biology54(2009) 5831–5846. doi:10.1088/0031-9155/54/19/011

  28. [36]

    Management of Motion and Anatomical Variations in Charged Particle Therapy: Past, Present, and Into the Future.Frontiers in Oncology12(2022) 1–16

    Pakela JM, Knopf A, Dong L, Rucinski A, Zou W. Management of Motion and Anatomical Variations in Charged Particle Therapy: Past, Present, and Into the Future.Frontiers in Oncology12(2022) 1–16. doi:10.3389/fonc.2022.806153

  29. [37]

    Particle therapy in the future of precision therapy.The British journal of radiology93(2020) 20200183

    Schaub L, Harrabi SB, Debus J. Particle therapy in the future of precision therapy.The British journal of radiology93(2020) 20200183. doi:10.1259/bjr.20200183

  30. [38]

    Quantitative analysis of treatment process time and throughput capacity for spot scanning proton therapy.Medical Physics 43(2016) 3975–3986

    Suzuki K, Palmer MB, Sahoo N, Zhang X, Poenisch F, MacKin DS, et al. Quantitative analysis of treatment process time and throughput capacity for spot scanning proton therapy.Medical Physics 43(2016) 3975–3986. doi:10.1118/1.4952731

  31. [39]

    Technical Note: Using experimentally determined proton spot scanning timing parameters to accurately model beam delivery time.Medical Physics44(2017) 5081–5088

    Shen J, Tryggestad E, Younkin JE, Keole SR, Furutani KM, Kang Y , et al. Technical Note: Using experimentally determined proton spot scanning timing parameters to accurately model beam delivery time.Medical Physics44(2017) 5081–5088. doi:10.1002/mp.12504

  32. [40]

    Retrospective analysis of reduced energy switching and room switching times on throughput efficiency of a multi-room proton therapy center.British Journal of Radiology93(2020)

    Mah D, Chen CC, Nawaz AO, Galbreath G, Shmulenson R, Lee N, et al. Retrospective analysis of reduced energy switching and room switching times on throughput efficiency of a multi-room proton therapy center.British Journal of Radiology93(2020). doi:10.1259/bjr.20190820. Frontie...

  33. [41]

    Pencil beam characteristics of the next-generation proton scanning gantry of PSI: Design issues and initial commissioning results.European Physical Journal Plus126(2011) 1–27

    Pedroni E, Meer D, Bula C, Safai S, Zenklusen S. Pencil beam characteristics of the next-generation proton scanning gantry of PSI: Design issues and initial commissioning results.European Physical Journal Plus126(2011) 1–27. doi:10.1140/epjp/i2011-11066-0

  34. [42]

    Effect of the initial energy layer and spot placement parameters on IMPT delivery efficiency and plan quality.Journal of Applied Clinical Medical Physics(2023) e13997

    Zhu M, Flampouri S, Stanforth A, Slopsema R, Diamond Z, LePain W, et al. Effect of the initial energy layer and spot placement parameters on IMPT delivery efficiency and plan quality.Journal of Applied Clinical Medical Physics(2023) e13997. doi:10.1002/acm2.13997

  35. [43]

    Mizushima K, Furukawa T, Iwata Y , Hara Y , Saotome N, Saraya Y , et al. Performance of the HIMAC beam control system using multiple-energy synchrotron operation.Nuclear Instruments and Methods in Physics Research, Section B: Beam Interactions with Materials and Atoms406(2017)...

  36. [44]

    Multiple energy extraction reduces beam delivery time for a synchrotron-based proton spot-scanning system.Advances in Radiation Oncology3(2018) 412–420

    Younkin JE, Bues M, Sio TT, Liu W, Ding X, Keole SR, et al. Multiple energy extraction reduces beam delivery time for a synchrotron-based proton spot-scanning system.Advances in Radiation Oncology3(2018) 412–420. doi:10.1016/j.adro.2018.02.006

  37. [45]

    The Influence of Motion on the Delivery Accuracy When Comparing Actively Scanned Carbon Ions versus Protons at a Synchrotron-Based Radiotherapy Facility.Cancers14(2022) 1–14

    Lebbink F, Stock M, Georg D, Kn¨ausl B. The Influence of Motion on the Delivery Accuracy When Comparing Actively Scanned Carbon Ions versus Protons at a Synchrotron-Based Radiotherapy Facility.Cancers14(2022) 1–14

  38. [46]

    Zhao L, Liu G, Chen S, Shen J, Zheng W, Qin A, et al. Developing an accurate model of spot- scanning treatment delivery time and sequence for a compact superconducting synchrocyclotron proton therapy system.Radiation Oncology17(2022) 87. doi:10.1186/s13014-022-02055-w

  39. [47]

    Beam commissioning of the first compact proton therapy system with spot scanning and dynamic field collimation.The British journal of radiology93(2020) 20190598

    Vilches-Freixas G, Unipan M, Rinaldi I, Martens J, Roijen E, Almeida IP, et al. Beam commissioning of the first compact proton therapy system with spot scanning and dynamic field collimation.The British journal of radiology93(2020) 20190598. doi:10.1259/bjr.20190598

  40. [48]

    Optimization of synchrotron based ion beam therapy facilities for treatment time reduction, options and the MedAustron development roadmap.Physica Medica81(2021) 264–272

    De Franco A, Schmitzer C, Gambino N, Glatzl T, Myalski S, Pivi M. Optimization of synchrotron based ion beam therapy facilities for treatment time reduction, options and the MedAustron development roadmap.Physica Medica81(2021) 264–272. doi:10.1016/j.ejmp.2020.11.029

  41. [50]

    Noda K, Furukawa T, Fujimoto T, Hara Y , Inaniwa T, Iwata Y , et al. Recent progress and future plans of heavy-ion cancer radiotherapy with HIMAC.Nuclear Instruments and Methods in Physics Research, Section B: Beam Interactions with Materials and Atoms406(2017) 374–378. doi:10...

  42. [51]

    3D range-modulator for scanned particle therapy: Development, Monte Carlo simulations and experimental evaluation

    Simeonov Y , Weber U, Penchev P, Ringbæk TP, Schuy C, Brons S, et al. 3D range-modulator for scanned particle therapy: Development, Monte Carlo simulations and experimental evaluation. Physics in Medicine and Biology62(2017) 7075–7096. doi:10.1088/1361-6560/aa81f4

  43. [52]

    Design and construction of a ripple filter for a smoothed depth dose distribution in conformal particle therapy.Physics in Medicine and Biology44(1999) 2765–2775

    Weber U, Kraft G. Design and construction of a ripple filter for a smoothed depth dose distribution in conformal particle therapy.Physics in Medicine and Biology44(1999) 2765–2775. doi:10.1088/ 0031-9155/44/11/306

  44. [53]

    The advantages and challenges of superconducting magnets in particle therapy.Superconductor Science and Technology29(2016)

    Gerbershagen A, Calzolaio C, Meer D, Sanfilippo S, Schippers M. The advantages and challenges of superconducting magnets in particle therapy.Superconductor Science and Technology29(2016). doi:10.1088/0953-2048/29/8/083001

  45. [54]

    A predictive algorithm for spot position corrections after fast energy switching in proton pencil beam scanning.Medical Physics45(2018) 4806–4815

    Psoroulas S, Bula C, Actis O, Weber DC, Meer D. A predictive algorithm for spot position corrections after fast energy switching in proton pencil beam scanning.Medical Physics45(2018) 4806–4815. doi:10.1002/mp.13217. This is a provisional file, not the final typeset article30 ...

  46. [55]

    Chaudhri N, Saito N, Bert C, Franczak B, Steidl P, Durante M, et al. Ion-optical studies for a range adaptation method in ion beam therapy using a static wedge degrader combined with magnetic beam deflection.Physics in Medicine and Biology55(2010) 3499–3513. doi:10.1088/0031-9...

  47. [56]

    The potential of Gantry beamline large momentum acceptance for real time tumour tracking in pencil beam scanning proton therapy

    Fattori G, Zhang Y , Meer D, Weber DC, Lomax AJ, Safai S. The potential of Gantry beamline large momentum acceptance for real time tumour tracking in pencil beam scanning proton therapy. Scientific Reports10(2020) 1–13. doi:10.1038/s41598-020-71821-1

  48. [57]

    Large energy acceptance gantry for proton therapy utilizing superconducting technology.Physics in Medicine and Biology64 (2019)

    Nesteruk KP, Calzolaio C, Meer D, Rizzoglio V , Seidel M, Schippers JM. Large energy acceptance gantry for proton therapy utilizing superconducting technology.Physics in Medicine and Biology64 (2019). doi:10.1088/1361-6560/ab2f5f

  49. [58]

    Commissioning and beam characterization of the first gantry-mounted accelerator pencil beam scanning proton system.Medical Physics47(2020) 3496–3510

    Kang M, Pang D. Commissioning and beam characterization of the first gantry-mounted accelerator pencil beam scanning proton system.Medical Physics47(2020) 3496–3510. doi:10.1002/mp.13972

  50. [59]

    Dosimetric evaluation of dose shaping by adaptive aperture and its impact on plan quality.Medical Dosimetry49(2024) 30–36

    Silvus A, Haefner J, Altman MB, Zhao T, Perkins S, Zhang T. Dosimetric evaluation of dose shaping by adaptive aperture and its impact on plan quality.Medical Dosimetry49(2024) 30–36. doi:10.1016/j.meddos.2023.10.011

  51. [60]

    Grewal HS, Ahmad S, Jin H. Performance evaluation of adaptive aperture’s static and dynamic collimation in a compact pencil beam scanning proton therapy system: A dosimetric comparison study for multiple disease sites.Medical Dosimetry46(2021) 179–187. doi:10.1016/j.meddos.2020.11.001

  52. [61]

    Clinical Implementation of Proton Therapy Using Pencil-Beam Scanning Delivery Combined With Static Apertures.Frontiers in Oncology11(2021) 1–11

    B¨aumer C, Plaude S, Khalil DA, Geismar D, Kramer PH, Kr¨oninger K, et al. Clinical Implementation of Proton Therapy Using Pencil-Beam Scanning Delivery Combined With Static Apertures.Frontiers in Oncology11(2021) 1–11. doi:10.3389/fonc.2021.599018

  53. [62]

    Characterization of penumbra sharpening and scattering by adaptive aperture for a compact pencil beam scanning proton therapy system.Medical Physics48(2021) 1508–1519

    Grewal HS, Ahmad S, Jin H. Characterization of penumbra sharpening and scattering by adaptive aperture for a compact pencil beam scanning proton therapy system.Medical Physics48(2021) 1508–1519. doi:10.1002/mp.14771

  54. [63]

    Operational and design aspects of accelerators for medical applications

    Schippers JM, Seidel M. Operational and design aspects of accelerators for medical applications. Physical Review Special Topics - Accelerators and Beams18(2015) 1–7. doi:10.1103/PhysRevSTAB. 18.034801

  55. [64]

    A novel beam optics concept in a particle therapy gantry utilizing the advantages of superconducting magnets.Zeitschrift fur Medizinische Physik26 (2016) 224–237

    Gerbershagen A, Meer D, Schippers JM, Seidel M. A novel beam optics concept in a particle therapy gantry utilizing the advantages of superconducting magnets.Zeitschrift fur Medizinische Physik26 (2016) 224–237. doi:10.1016/j.zemedi.2016.03.006

  56. [65]

    Beam properties within the momentum acceptance of a clinical gantry beamline for proton therapy.Medical Physics(2021) 1–15

    Giovannelli AC, Maradia V , Meer D, Safai S, Psoroulas S, Togno M, et al. Beam properties within the momentum acceptance of a clinical gantry beamline for proton therapy.Medical Physics(2021) 1–15. doi:10.1002/mp.15449

  57. [66]

    Precise beam delivery for proton therapy with dynamic energy modulation.Journal of Physics: Conference Series1067(2018)

    Actis O, Mayor A, Meer D, Weber D. Precise beam delivery for proton therapy with dynamic energy modulation.Journal of Physics: Conference Series1067(2018). doi:10.1088/1742-6596/1067/9/ 092002

  58. [67]

    A bi-directional beam-line energy ramping for efficient patient treatment with scanned proton therapy.Physics in Medicine & Biology68(2023) 175001

    Actis O, Mayor A, Meer D, Rechsteiner U, Bolsi A, Lomax AJ, et al. A bi-directional beam-line energy ramping for efficient patient treatment with scanned proton therapy.Physics in Medicine & Biology68(2023) 175001. doi:10.1088/1361-6560/acebb2

  59. [68]

    Operational Improvement of a Proton Therapy System From Reduced Energy Layer Switching Time.International Journal of Particle Therapy16(2025) 100742

    Artz ME, Grewal HS, Zhang Y , Johnson PB, Saki M, Schreuder N, et al. Operational Improvement of a Proton Therapy System From Reduced Energy Layer Switching Time.International Journal of Particle Therapy16(2025) 100742. doi:10.1016/j.ijpt.2025.100742

  60. [69]

    Simultaneous reduction of number of spots and energy layers in intensity modulated proton therapy for rapid spot scanning delivery.Medical Physics(2024) mp.17070

    Fu A, Taasti VT, Zarepisheh M. Simultaneous reduction of number of spots and energy layers in intensity modulated proton therapy for rapid spot scanning delivery.Medical Physics(2024) mp.17070. doi:10.1002/mp.17070. Frontiers 31 Yap et al.Toward Ultra-fast PBT Treatments

  61. [70]

    The use of a mini-ridge filter with cyclotron-based pencil beam scanning proton therapy.Medical Physics(2023) mp.16254

    O’Grady F, Janson M, Rao AD, Chawla AK, Stephenson L, Fan J, et al. The use of a mini-ridge filter with cyclotron-based pencil beam scanning proton therapy.Medical Physics(2023) mp.16254. doi:10.1002/mp.16254

  62. [71]

    Prioritized efficiency optimization for intensity modulated proton therapy

    M¨uller BS, Wilkens JJ. Prioritized efficiency optimization for intensity modulated proton therapy. Physics in Medicine and Biology61(2016) 8249–8265. doi:10.1088/0031-9155/61/23/8249

  63. [72]

    Proton therapy of lung cancer patients – Treatment strategies and clinical experience from a medical physicist’s perspective.Physica Medica130(2025) 104890

    Taasti VT, Kneepkens E, van der Stoep J, Velders M, Cobben M, Vullings A, et al. Proton therapy of lung cancer patients – Treatment strategies and clinical experience from a medical physicist’s perspective.Physica Medica130(2025) 104890. doi:10.1016/j.ejmp.2024.104890

  64. [73]

    Motion management in particle therapy.Medical Physics45(2018) e994–e1010

    Mori S, Knopf AC, Umegaki K. Motion management in particle therapy.Medical Physics45(2018) e994–e1010. doi:10.1002/mp.12679

  65. [74]

    Motion mitigation in scanned ion beam therapy through 4D-optimization.Physica Medica 30(2014) 570–577

    Graeff C. Motion mitigation in scanned ion beam therapy through 4D-optimization.Physica Medica 30(2014) 570–577. doi:10.1016/j.ejmp.2014.03.011

  66. [75]

    A review of the clinical introduction of 4D particle therapy research concepts.Physics and Imaging in Radiation Oncology (2024) 100535

    Kn¨ausl B, Belotti G, Bertholet J, Daartz J, Flampouri S, Hoogeman M, et al. A review of the clinical introduction of 4D particle therapy research concepts.Physics and Imaging in Radiation Oncology (2024) 100535. doi:10.1016/j.phro.2024.100535

  67. [76]

    Physics Controversies in Proton Therapy.Seminars in Radiation Oncology23(2013) 88–96

    Engelsman M, Schwarz M, Dong L. Physics Controversies in Proton Therapy.Seminars in Radiation Oncology23(2013) 88–96. doi:10.1016/j.semradonc.2012.11.003

  68. [77]

    Effects of respiratory motion on dose uniformity with a charged particle scanning method.Physics in Medicine and Biology37 (1992) 223–234

    Phillips MH, Pedroni E, Blattmann H, Boehringer T, Coray A, Scheib S. Effects of respiratory motion on dose uniformity with a charged particle scanning method.Physics in Medicine and Biology37 (1992) 223–234. doi:10.1088/0031-9155/37/1/016

  69. [78]

    Quantification of interplay effects of scanned particle beams and moving targets.Physics in Medicine and Biology53(2008) 2253–2265

    Bert C, Gr¨ozinger SO, Rietzel E. Quantification of interplay effects of scanned particle beams and moving targets.Physics in Medicine and Biology53(2008) 2253–2265. doi:10.1088/0031-9155/53/ 9/003

  70. [79]

    Shan J, Yang Y , Schild SE, Daniels TB, Wong WW, Fatyga M, et al. Intensity-modulated proton therapy (IMPT) interplay effect evaluation of asymmetric breathing with simultaneous uncertainty considerations in patients with non-small cell lung cancer.Medical Physics47(2020) 5428...

  71. [80]

    Dosimetric consequences of tumour motion due to respiration for a scanned proton beam.Physics in Medicine and Biology56(2011) 6563–6581

    Kraus KM, Heath E, Oelfke U. Dosimetric consequences of tumour motion due to respiration for a scanned proton beam.Physics in Medicine and Biology56(2011) 6563–6581. doi:10.1088/ 0031-9155/56/20/003

  72. [81]

    Li H, Zhu XR, Zhang X. Reducing Dose Uncertainty for Spot-Scanning Proton Beam Therapy of Moving Tumors by Optimizing the Spot Delivery Sequence.International Journal of Radiation Oncology Biology Physics93(2015) 547–556. doi:10.1016/j.ijrobp.2015.06.019

  73. [82]

    A study of the beam-specific interplay effect in proton pencil beam scanning delivery in lung cancer.Acta Oncologica56(2017) 531–540

    Kang M, Huang S, Solberg TD, Mayer R, Thomas A, Teo BKK, et al. A study of the beam-specific interplay effect in proton pencil beam scanning delivery in lung cancer.Acta Oncologica56(2017) 531–540. doi:10.1080/0284186X.2017.1293287

  74. [83]

    Proton therapy in clinical practice.Chinese Journal of Cancer30(2011) 315–326

    Liu H, Chang JY . Proton therapy in clinical practice.Chinese Journal of Cancer30(2011) 315–326. doi:10.5732/cjc.010.10529

  75. [84]

    K¨othe A, Lomax AJ, Giovannelli AC, Safai S, Bizzocchi N, Roelofs E, et al. The impact of organ motion and the appliance of mitigation strategies on the effectiveness of hypoxia-guided proton therapy for non-small cell lung cancer.Radiotherapy and Oncology176(2022) 208–214. do...

  76. [85]

    4-Dimensional Computed Tomography Imaging and Treatment Planning.Seminars in Radiation Oncology14(2004) 81–90

    Keall P. 4-Dimensional Computed Tomography Imaging and Treatment Planning.Seminars in Radiation Oncology14(2004) 81–90. doi:10.1053/j.semradonc.2003.10.006. This is a provisional file, not the final typeset article32 Yap et al.Toward Ultra-fast PBT Treatments

  77. [86]

    Intrafraction motion during partial breast irradiation depends on treatment time.Radiotherapy and Oncology159(2021) 176–182

    Hoekstra N, Habraken S, Swaak-Kragten A, Hoogeman M, Pignol JP. Intrafraction motion during partial breast irradiation depends on treatment time.Radiotherapy and Oncology159(2021) 176–182. doi:10.1016/j.radonc.2021.03.029

  78. [87]

    Time Dependence of Intrafraction Patient Motion Assessed by Repeat Stereoscopic Imaging.International Journal of Radiation Oncology*Biology*Physics70(2008) 609–618

    Hoogeman MS, Nuyttens JJ, Levendag PC, Heijmen BJ. Time Dependence of Intrafraction Patient Motion Assessed by Repeat Stereoscopic Imaging.International Journal of Radiation Oncology*Biology*Physics70(2008) 609–618. doi:10.1016/j.ijrobp.2007.08.066

  79. [88]

    Motion in radiotherapy: Particle therapy.Physics in Medicine and Biology56 (2011) R113–R144

    Bert C, Durante M. Motion in radiotherapy: Particle therapy.Physics in Medicine and Biology56 (2011) R113–R144. doi:10.1088/0031-9155/56/16/R01

  80. [89]

    Range Verification Methods in Particle Therapy: Underlying Physics and Monte Carlo Modeling.Frontiers in Oncology5(2015) 150

    Kraan AC. Range Verification Methods in Particle Therapy: Underlying Physics and Monte Carlo Modeling.Frontiers in Oncology5(2015) 150. doi:10.3389/fonc.2015.00150

  81. [90]

    In vivo proton range verification: A review.Physics in Medicine and Biology 58(2013) R131–R160

    Knopf AC, Lomax A. In vivo proton range verification: A review.Physics in Medicine and Biology 58(2013) R131–R160. doi:10.1088/0031-9155/58/15/R131

  82. [91]

    A survey of practice patterns for real-time intrafractional motion-management in particle therapy.Physics and Imaging in Radiation Oncology26(2023) 100439

    Zhang Y , Trnkova P, Toshito T, Heijmen B, Richter C, Aznar M, et al. A survey of practice patterns for real-time intrafractional motion-management in particle therapy.Physics and Imaging in Radiation Oncology26(2023) 100439. doi:10.1016/j.phro.2023.100439

  83. [92]

    Respiratory motion management in particle therapy.Medical Physics37(2010) 449–460

    Rietzel E, Bert C. Respiratory motion management in particle therapy.Medical Physics37(2010) 449–460. doi:10.1118/1.3250856

  84. [93]

    Poulsen PR, Eley J, Langner U, Simone CB, Langen K. Efficient Interplay Effect Mitigation for Proton Pencil Beam Scanning by Spot-Adapted Layered Repainting Evenly Spread out Over the Full Breathing Cycle.International Journal of Radiation Oncology Biology Physics100(2018) 226...

  85. [94]

    Younkin JE, Morales DH, Shen J, Ding X, Stoker JB, Yu NY , et al. Technical Note: Multiple energy extraction techniques for synchrotron-based proton delivery systems may exacerbate motion interplay effects in lung cancer treatments.Medical Physics48(2021) 4812–4823. doi:10.100...

  86. [95]

    Maximum proton kinetic energy and patient-generated neutron fluence considerations in proton beam arc delivery radiation therapy

    Sengbusch E, P ´erez-And´ujar A, DeLuca PM, Mackie TR. Maximum proton kinetic energy and patient-generated neutron fluence considerations in proton beam arc delivery radiation therapy. Medical Physics36(2009) 364–372. doi:10.1118/1.3049787

  87. [96]

    Does the Maximum Initial Beam Energy for Proton Therapy Have to Be 230 MeV?Quantum Beam Science8(2024) 23

    Beltran CJ, Perales A, Furutani KM. Does the Maximum Initial Beam Energy for Proton Therapy Have to Be 230 MeV?Quantum Beam Science8(2024) 23. doi:10.3390/qubs8030023

  88. [97]

    Improving delivery efficiency using spots and energy layers reduction algorithms based on a large momentum acceptance beamline.Medical Physics(2023) mp.16420

    Wang W, Liu X, Yang Z, Liao Y , Li P, Zhao R, et al. Improving delivery efficiency using spots and energy layers reduction algorithms based on a large momentum acceptance beamline.Medical Physics(2023) mp.16420. doi:10.1002/mp.16420

  89. [98]

    Exploring beamline momentum acceptance for tracking respiratory variability in lung cancer proton therapy: A simulation study

    Giovannelli AC, K¨othe A, Safai S, Meer D, Zhang Y , Weber DC, et al. Exploring beamline momentum acceptance for tracking respiratory variability in lung cancer proton therapy: A simulation study. Physics in Medicine & Biology(2023). doi:10.1088/1361-6560/acf5c4

  90. [99]

    Energy layer optimization strategies for intensity-modulated proton therapy of lung cancer patients.Medical Physics45(2018) 4355–4363

    Jensen MF, Hoffmann L, Petersen JBB, Møller DS, Alber M. Energy layer optimization strategies for intensity-modulated proton therapy of lung cancer patients.Medical Physics45(2018) 4355–4363. doi:10.1002/mp.13139

  91. [100]

    Proton energy optimization and reduction for intensity-modulated proton therapy.Physics in Medicine and Biology59(2014) 6341–6354

    Cao W, Lim G, Liao L, Li Y , Jiang S, Li X, et al. Proton energy optimization and reduction for intensity-modulated proton therapy.Physics in Medicine and Biology59(2014) 6341–6354. doi:10.1088/0031-9155/59/21/6341

  92. [101]

    Minimum-MU and sparse-energy-layer (MMSEL) constrained inverse optimization method for efficiently deliverable PBS plans.Physics in Medicine & Biology64(2019) 205001

    Lin Y , Clasie B, Liu T, McDonald M, Langen KM, Gao H. Minimum-MU and sparse-energy-layer (MMSEL) constrained inverse optimization method for efficiently deliverable PBS plans.Physics in Medicine & Biology64(2019) 205001. doi:10.1088/1361-6560/ab4529. Frontiers 33 Yap et al.To...

  93. [102]

    Gao H, Clasie B, McDonald M, Langen KM, Liu T, Lin Y . Technical Note: Plan-delivery-time constrained inverse optimization method with minimum-MU-per-energy-layer (MMPEL) for efficient pencil beam scanning proton therapy.Medical Physics47(2020) 3892–3897. doi:10.1002/mp.14363

  94. [105]

    Cardinality-constrained plan-quality and delivery-time optimization method for proton therapy.Medical Physics51(2024) 4567–4580

    Lin B, Li Y , Liu B, Fu S, Lin Y , Gao H. Cardinality-constrained plan-quality and delivery-time optimization method for proton therapy.Medical Physics51(2024) 4567–4580. doi:10.1002/mp. 17249

  95. [106]

    Kang M, Wei S, Choi JI, Lin H, Simone CB. A Universal Range Shifter and Range Compensator Can Enable Proton Pencil Beam Scanning Single-Energy Bragg Peak FLASH-RT Treatment Using Current Commercially Available Proton Systems.International Journal of Radiation Oncology*Biology*...

  96. [107]

    Bridging research and clinical practice in ultra-high dose rate proton therapy.The European Physical Journal Plus(2025)

    Schwarz M. Bridging research and clinical practice in ultra-high dose rate proton therapy.The European Physical Journal Plus(2025)

  97. [108]

    Design of static and dynamic ridge filters for FLASH–IMPT: A simulation study.Medical Physics49(2022) 5387–5399

    Zhang G, Gao W, Peng H. Design of static and dynamic ridge filters for FLASH–IMPT: A simulation study.Medical Physics49(2022) 5387–5399. doi:10.1002/mp.15717

  98. [109]

    A Novel Energy Modulator Design Concept for FLASH Proton Therapy.Current Directions in Biomedical Engineering11(2025) 1–4

    Hagmann V , Colizzi I, Ambruosi A, Lomax AJ, Meer D, Psoroulas S, et al. A Novel Energy Modulator Design Concept for FLASH Proton Therapy.Current Directions in Biomedical Engineering11(2025) 1–4. doi:10.1515/cdbme-2025-0101

  99. [110]

    Experimental validation of coarse ridge filters for FLASH proton therapy.Medical Physics52(2025) e18044

    Hotoiu L, Stappen FV , Pin A, Nilsson R, Ivoc J, Kim M, et al. Experimental validation of coarse ridge filters for FLASH proton therapy.Medical Physics52(2025) e18044. doi:10.1002/mp.18044

  100. [111]

    Commissioning of a clinical pencil beam scanning proton therapy unit for ultra-high dose rates (FLASH).Medical Physics48(2021) 4017–4026

    Nesteruk KP, Togno M, Grossmann M, Lomax AJ, Weber DC, Schippers JM, et al. Commissioning of a clinical pencil beam scanning proton therapy unit for ultra-high dose rates (FLASH).Medical Physics48(2021) 4017–4026. doi:10.1002/mp.14933

  101. [112]

    Feasibility study of multiple-energy Bragg peak proton FLASH on a superconducting gantry with large momentum acceptance.Medical Physics (2024) mp.16932

    Zeng Y , Li H, Wang W, Liu X, Qin B, Dai S, et al. Feasibility study of multiple-energy Bragg peak proton FLASH on a superconducting gantry with large momentum acceptance.Medical Physics (2024) mp.16932. doi:10.1002/mp.16932

  102. [113]

    Treatment parameters consideration for universal range shifter-based multi-energy proton FLASH-RT.Medical Physics52(2025) e70039

    Zeng Y , Quan H, Zhang Q, Wang W, Liu X, Qin B, et al. Treatment parameters consideration for universal range shifter-based multi-energy proton FLASH-RT.Medical Physics52(2025) e70039. doi:10.1002/mp.70039

  103. [114]

    Ultra-High dose rate radiation production and delivery systems intended for FLASH.Medical Physics(2022) 1–37

    Farr J, Grilj V , Malka V , Sudharsan S, Schippers M. Ultra-High dose rate radiation production and delivery systems intended for FLASH.Medical Physics(2022) 1–37. doi:10.1002/mp.15659

  104. [115]

    Biological and Mechanical Synergies to Deal With Proton Therapy Pitfalls: Minibeams, FLASH, Arcs, and Gantryless Rooms.Frontiers in Oncology10(2021) 1–14

    Mazal A, Vera Sanchez JA, Sanchez-Parcerisa D, Udias JM, Espa˜na S, Sanchez-Tembleque V , et al. Biological and Mechanical Synergies to Deal With Proton Therapy Pitfalls: Minibeams, FLASH, Arcs, and Gantryless Rooms.Frontiers in Oncology10(2021) 1–14. doi:10.3389/fonc.2020.613669

  105. [116]

    Technical challenges for FLASH proton therapy.Physica Medica78(2020) 71–82

    Jolly S, Owen H, Schippers M, Welsch C. Technical challenges for FLASH proton therapy.Physica Medica78(2020) 71–82. doi:10.1016/j.ejmp.2020.08.005

  106. [117]

    Physics and biology of ultrahigh dose-rate (FLASH) radiotherapy: A topical review.Physics in Medicine and Biology65(2020)

    Esplen N, Mendonca MS, Bazalova-Carter M. Physics and biology of ultrahigh dose-rate (FLASH) radiotherapy: A topical review.Physics in Medicine and Biology65(2020). doi:10.1088/1361-6560/ abaa28. This is a provisional file, not the final typeset article34 Yap et al.Toward Ultr...

  107. [118]

    Navigating the straits: Realizing the potential of proton FLASH through physics advances and further pre-clinical characterization

    Fenwick JD, Mayhew C, Jolly S, Amos RA, Hawkins MA. Navigating the straits: Realizing the potential of proton FLASH through physics advances and further pre-clinical characterization. Frontiers in Oncology14(2024) 1420337. doi:10.3389/fonc.2024.1420337

  108. [119]

    The first direct method of spot sparsity optimization for proton arc therapy.Acta Oncologica62(2023) 48–52

    Zhao L, You J, Liu G, Wuyckens S, Lu X, Ding X. The first direct method of spot sparsity optimization for proton arc therapy.Acta Oncologica62(2023) 48–52. doi:10.1080/0284186X.2023.2172689

  109. [120]

    Fast robust optimization of proton PBS arc therapy plans using early energy layer selection and spot assignment.Physics in Medicine & Biology67(2022) 065010

    Engwall E, Battinelli C, Wase V , Marthin O, Glimelius L, Bokrantz R, et al. Fast robust optimization of proton PBS arc therapy plans using early energy layer selection and spot assignment.Physics in Medicine & Biology67(2022) 065010. doi:10.1088/1361-6560/ac55a6

  110. [121]

    A novel energy sequence optimization algorithm for efficient spot-scanning proton arc (SPArc) treatment delivery.Acta Oncologica59 (2020) 1178–1185

    Liu G, Li X, Zhao L, Zheng W, Qin A, Zhang S, et al. A novel energy sequence optimization algorithm for efficient spot-scanning proton arc (SPArc) treatment delivery.Acta Oncologica59 (2020) 1178–1185. doi:10.1080/0284186X.2020.1765415

  111. [122]

    A novel energy layer optimization framework for spot-scanning proton arc therapy.Medical Physics47(2020) 2072–2084

    Gu W, Ruan D, Lyu Q, Zou W, Dong L, Sheng K. A novel energy layer optimization framework for spot-scanning proton arc therapy.Medical Physics47(2020) 2072–2084. doi:10.1002/mp.14083

  112. [123]

    Treatment planning of scanned proton beams in RayStation.Medical Dosimetry49(2024) 2–12

    Janson M, Glimelius L, Fredriksson A, Traneus E, Engwall E. Treatment planning of scanned proton beams in RayStation.Medical Dosimetry49(2024) 2–12. doi:10.1016/j.meddos.2023.10.009

  113. [124]

    Static proton arc therapy: Comprehensive plan quality evaluation and first clinical treatments in patients with complex head and neck targets.Medical Physics(2025) mp.17669

    Fracchiolla F, Engwall E, Mikhalev V , Cianchetti M, Giacomelli I, Siniscalchi B, et al. Static proton arc therapy: Comprehensive plan quality evaluation and first clinical treatments in patients with complex head and neck targets.Medical Physics(2025) mp.17669. doi:10.1002/mp.17669

  114. [125]

    Explore the feasibility of using spot-scanning proton arc therapy for a synchrotron accelerator-based proton therapy system – A simulation study

    Cong X, Liu G, Liu P, Zhao L, Chen S, Li X, et al. Explore the feasibility of using spot-scanning proton arc therapy for a synchrotron accelerator-based proton therapy system – A simulation study. Journal of Applied Clinical Medical Physics(2024) e14526. doi:10.1002/acm2.14526

  115. [126]

    Ding X, Li X, Zhang JM, Kabolizadeh P, Stevens C, Yan D. Spot-Scanning Proton Arc (SPArc) Therapy: The First Robust and Delivery-Efficient Spot-Scanning Proton Arc Therapy.International Journal of Radiation Oncology Biology Physics96(2016) 1107–1116. doi:10.1016/j.ijrobp.2016.08. 049

  116. [127]

    Fixed beamlines can replace gantries for particle therapy.Medical Physics(2022) 1–4

    Schreuder N, Ding X, Li Z. Fixed beamlines can replace gantries for particle therapy.Medical Physics(2022) 1–4. doi:10.1002/mp.15531

  117. [128]

    Opportunities and challenges of upright patient positioning in radiotherapy.Physics in Medicine & Biology(2024)

    V olz L, Korte JC, Martire MC, Zhang Y , Hardcastle N, Durante M, et al. Opportunities and challenges of upright patient positioning in radiotherapy.Physics in Medicine & Biology(2024). doi:10.1088/1361-6560/ad70ee

  118. [129]

    Underwood T, Yan S, Bortfeld T, Gr´egoire V , Lomax T. A Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis for Gantry-Less Upright Radiation Therapy.International Journal of Radiation Oncology*Biology*Physics122(2025) 1337–1343. doi:10.1016/j.ijrobp.2025.02.039

  119. [130]

    Considerations for Upright Particle Therapy Patient Positioning and Associated Image Guidance.Frontiers in Oncology12(2022) 13

    V olz L. Considerations for Upright Particle Therapy Patient Positioning and Associated Image Guidance.Frontiers in Oncology12(2022) 13

  120. [131]

    Particle arc therapy: Status and potential.Radiotherapy and Oncology(2024) 110434

    Mein S, Wuyckens S, Li X, Both S, Carabe A, Vera MC, et al. Particle arc therapy: Status and potential.Radiotherapy and Oncology(2024) 110434. doi:10.1016/j.radonc.2024.110434

  121. [132]

    An evaluation of rescanning technique for liver tumour treatments using a commercial PBS proton therapy system.Radiotherapy and Oncology121 (2016) 281–287

    Zhang Y , Huth I, Wegner M, Weber DC, Lomax AJ. An evaluation of rescanning technique for liver tumour treatments using a commercial PBS proton therapy system.Radiotherapy and Oncology121 (2016) 281–287. doi:10.1016/j.radonc.2016.09.011

  122. [133]

    Experimental verification of motion mitigation of discrete proton spot scanning by re-scanning.Physics in Medicine and Biology58(2013) 8555–8572

    Sch¨atti A, Zakova M, Meer D, Lomax AJ. Experimental verification of motion mitigation of discrete proton spot scanning by re-scanning.Physics in Medicine and Biology58(2013) 8555–8572. doi:10.1088/0031-9155/58/23/8555

  123. [134]

    Intrafractional motion during proton beam scanning.Physics in Medicine and Biology50(2005) 4853–4862

    Lambert J, Suchowerska N, McKenzie DR, Jackson M. Intrafractional motion during proton beam scanning.Physics in Medicine and Biology50(2005) 4853–4862. doi:10.1088/0031-9155/50/20/008. Frontiers 35 Yap et al.Toward Ultra-fast PBT Treatments

  124. [135]

    Current status of proton therapy techniques for lung cancer.Radiation Oncology Journal37 (2019) 232–248

    Han Y . Current status of proton therapy techniques for lung cancer.Radiation Oncology Journal37 (2019) 232–248. doi:10.3857/roj.2019.00633

  125. [136]

    Effectiveness of different rescanning techniques for scanned proton radiotherapy in lung cancer patients.Physics in Medicine and Biology63(2018) aabb7b

    Engwall E, Glimelius L, Hynning E. Effectiveness of different rescanning techniques for scanned proton radiotherapy in lung cancer patients.Physics in Medicine and Biology63(2018) aabb7b. doi:10.1088/1361-6560/aabb7b

  126. [137]

    Comparative study of layered and volumetric rescanning for different scanning speeds of proton beam in liver patients.Physics in Medicine and Biology58 (2013) 7905–7920

    Bernatowicz K, Lomax AJ, Knopf A. Comparative study of layered and volumetric rescanning for different scanning speeds of proton beam in liver patients.Physics in Medicine and Biology58 (2013) 7905–7920. doi:10.1088/0031-9155/58/22/7905

  127. [138]

    The effectiveness of combined gating and re-scanning for treating mobile targets with proton spot scanning

    Sch¨atti A, Zakova M, Meer D, Lomax AJ. The effectiveness of combined gating and re-scanning for treating mobile targets with proton spot scanning. An experimental and simulation-based investigation. Physics in Medicine and Biology59(2014) 3813–3828. doi:10.1088/0031-9155/59/14/3813

  128. [139]

    Evaluation of spot size using volumetric repainting technique on a ProteusPLUS PBS Proton Therapy System.Journal of Physics: Conference Series 1662(2020) 012027

    Rana S, Bennouna J, Gutierrez A, Rosenfeld A. Evaluation of spot size using volumetric repainting technique on a ProteusPLUS PBS Proton Therapy System.Journal of Physics: Conference Series 1662(2020) 012027. doi:10.1088/1742-6596/1662/1/012027

  129. [140]

    Rana S, Bennouna J, Gutierrez AN, Rosenfeld AB. Impact of magnetic field regulation in conjunction with the volumetric repainting technique on the spot positions and beam range in pencil beam scanning proton therapy.Journal of Applied Clinical Medical Physics21(2020) 124–131. ...

  130. [141]

    Dose detectors, sensors, and their applications.Medical Physics45 (2018) e1051–e1072

    Giordanengo S, Palmans H. Dose detectors, sensors, and their applications.Medical Physics45 (2018) e1051–e1072

  131. [142]

    Schoemers C, Feldmeier E, Naumann J, Panse R, Peters A, Haberer T. The intensity feedback system at Heidelberg Ion-Beam Therapy Centre.Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment795(2015) 92–99...

  132. [143]

    Design, integration, and commissioning of the first linac for image guided hadron therapy prototype.Physical Review Accelerators and Beams27(2024) 054701

    Degiovanni A, De Michele G, Bonomi R, Cabaleiro Magallanes F, Caldara M, Dimov V , et al. Design, integration, and commissioning of the first linac for image guided hadron therapy prototype.Physical Review Accelerators and Beams27(2024) 054701. doi:10.1103/PhysRevAccelBeams.27.054701

  133. [144]

    Peach KJ, Aslaninejad M, Barlow RJ, Beard CD, Bliss N, Cobb JH, et al. Conceptual design of a nonscaling fixed field alternating gradient accelerator for protons and carbon ions for charged particle therapy.Physical Review Special Topics - Accelerators and Beams16(2013) 1–34. ...

  134. [145]

    Oblique raster scanning: An ion dose delivery procedure with variable energy layers

    Amaldi U. Oblique raster scanning: An ion dose delivery procedure with variable energy layers. Physics in Medicine and Biology64(2019). doi:10.1088/1361-6560/ab0920

  135. [146]

    Beam delivery characteristics of the Hitachi carbon ion scanning system at Osaka Heavy Ion Medical Accelerator in Kansai (HIMAK).Medical Physics(2023) mp.16791

    Tsubouchi T, Beltran CJ, Yagi M, Hamatani N, Takashina M, Shimizu S, et al. Beam delivery characteristics of the Hitachi carbon ion scanning system at Osaka Heavy Ion Medical Accelerator in Kansai (HIMAK).Medical Physics(2023) mp.16791. doi:10.1002/mp.16791

  136. [147]

    Dosimetric consequences of flap dose due to rapid beam off control for a high intensity carbon ion radiation therapy synchrotron

    Tsubouchi T, Furutani KM, Yagi M, Nomura T, Shimizu S, Kanai T, et al. Dosimetric consequences of flap dose due to rapid beam off control for a high intensity carbon ion radiation therapy synchrotron. Medical Physics(2024) mp.17309. doi:10.1002/mp.17309

  137. [148]

    FLASH instead of proton arc therapy is a more promising advancement for the next generation proton radiotherapy.Journal of Applied Clinical Medical Physics24(2023) e14091

    Kang M, Ding X, Rong Y . FLASH instead of proton arc therapy is a more promising advancement for the next generation proton radiotherapy.Journal of Applied Clinical Medical Physics24(2023) e14091. doi:10.1002/acm2.14091

  138. [149]

    Cyclotron Versus Synchrotron for Proton Beam Therapy.Proceedings of the 14th International Conference on Cyclotrons and their Applications(1995) 533–536

    Fukumoto S. Cyclotron Versus Synchrotron for Proton Beam Therapy.Proceedings of the 14th International Conference on Cyclotrons and their Applications(1995) 533–536. This is a provisional file, not the final typeset article36 Yap et al.Toward Ultra-fast PBT Treatments

  139. [150]

    Emerging technologies in proton therapy.Acta Oncologica50(2011) 838–850

    Schippers JM, Lomax AJ. Emerging technologies in proton therapy.Acta Oncologica50(2011) 838–850. doi:10.3109/0284186X.2011.582513

  140. [151]

    Beam Delivery Systems for Particle Therapy: Current Status and Recent Developments

    Schippers M. Beam Delivery Systems for Particle Therapy: Current Status and Recent Developments. Reviews of Accelerator Science and Technology2(2009) 179–200

  141. [152]

    Indiana University Cyclotron Operation For Proton Therapy Facility.Cyclotrons and Their Applications(2007)

    Anferov V A, Ball MS, Collins JC, Derenchuk VP. Indiana University Cyclotron Operation For Proton Therapy Facility.Cyclotrons and Their Applications(2007)

  142. [153]

    Simulations and measurements of proton beam energy spectrum after energy degradation.Journal of Physics: Conference Series874(2017) 012108

    Gerbershagen A, Adelmann A, D ¨olling R, Meer D, Rizzoglio V , Schippers JM. Simulations and measurements of proton beam energy spectrum after energy degradation.Journal of Physics: Conference Series874(2017) 012108. doi:10.1088/1742-6596/874/1/012108

  143. [154]

    Schippers JM. Beam-Transport Systems for Particle Therapy.Proceedings of the CAS-CERN Accelerator School: Accelerators for Medical Applications, V¨osendorf, Austria, 26 May–5 June 2015 (2017), vol. 1, 241–252. doi:10.23730/CYRSP-2017-001.241

  144. [155]

    A performance study of the Loma Linda proton medical accelerator.Medical Physics21(1994) 1691–1701

    Coutrakon G, Hubbard J, Johanning J, Maudsley G, Slaton T, Morton P. A performance study of the Loma Linda proton medical accelerator.Medical Physics21(1994) 1691–1701. doi:10.1118/1. 597270

  145. [156]

    Rotatorlike gantry optics

    Pavloviˇc M, Pivi MTF, Straˇs´ık I, Rizzoglio V , Pullia MG, Adler L, et al. Rotatorlike gantry optics. Physical Review Accelerators and Beams27(2024) 073502. doi:10.1103/PhysRevAccelBeams.27. 073502

  146. [157]

    Hadron cancer therapy complex using nonscaling fixed field alternating gradient accelerator and gantry design.Physical Review Special Topics - Accelerators and Beams10(2007) 4–11

    Keil E, Sessler AM, Trbojevic D. Hadron cancer therapy complex using nonscaling fixed field alternating gradient accelerator and gantry design.Physical Review Special Topics - Accelerators and Beams10(2007) 4–11. doi:10.1103/PhysRevSTAB.10.054701

  147. [158]

    Normal-conducting scaling fixed field alternating gradient accelerator for proton therapy.Physical Review Special Topics - Accelerators and Beams18 (2015) 094701

    Garland JM, Appleby RB, Owen H, Tygier S. Normal-conducting scaling fixed field alternating gradient accelerator for proton therapy.Physical Review Special Topics - Accelerators and Beams18 (2015) 094701. doi:10.1103/PhysRevSTAB.18.094701

  148. [159]

    Taylor J, Edgecock TR, Johnstone C. HEATHER – HElium ion Accelerator for radioTHERapy.13th International Topical Meeting on Nuclear Applications of Accelerators 2017, AccApp 2017: The Expanding Universe of Accelerator Applications(2018) 368–376

  149. [160]

    RACCAM: An example of spiral sector scaling FFA technology

    Meot F. RACCAM: An example of spiral sector scaling FFA technology. Tech. Rep. BNL–211536- 2019-NEWS, 1507116, Brookhaven National Laboratory (2019)

  150. [161]

    LhARA: The Laser-hybrid Accelerator for Radiobiological Applications.Frontiers in Physics8(2020) 1–21

    Aymar G, Becker T, Boogert S, Borghesi M, Bingham R, Brenner C, et al. LhARA: The Laser-hybrid Accelerator for Radiobiological Applications.Frontiers in Physics8(2020) 1–21. doi:10.3389/fphy. 2020.567738

  151. [162]

    Fenning R.Novel FFAG Gantry and Transport Line Designs for Charged Particle Therapy. Ph.D. thesis, Brunel University (2011)

  152. [163]

    Alternating-gradient canted cosine theta superconducting magnets for future compact proton gantries.Physical Review Special Topics - Accelerators and Beams18(2015) 103501

    Wan W, Brouwer L, Caspi S, Prestemon S, Gerbershagen A, Schippers JM, et al. Alternating-gradient canted cosine theta superconducting magnets for future compact proton gantries.Physical Review Special Topics - Accelerators and Beams18(2015) 103501. doi:10.1103/PhysRevSTAB.18.103501

  153. [164]

    An achromatic gantry for proton therapy with fixed-field superconducting magnets.International Journal of Modern Physics A34(2019)

    Brouwer L, Huggins A, Wan W. An achromatic gantry for proton therapy with fixed-field superconducting magnets.International Journal of Modern Physics A34(2019). doi:10.1142/ S0217751X19420235

  154. [165]

    Beam optics of a superconducting proton-therapy gantry with a large momentum acceptance.International Journal of Modern Physics A34(2019) 1–8

    Nesteruk KP, Calzolaio C, Seidel M, Schippers JM. Beam optics of a superconducting proton-therapy gantry with a large momentum acceptance.International Journal of Modern Physics A34(2019) 1–8. doi:10.1142/S0217751X19420247. Frontiers 37 Yap et al.Toward Ultra-fast PBT Treatments

  155. [166]

    GaToroid: A novel toroidal gantry for hadron therapy

    Bottura L, Felcini E, De Rijk G, Dutoit B. GaToroid: A novel toroidal gantry for hadron therapy. Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment983(2020) 164588. doi:10.1016/j.nima.2020.164588

  156. [167]

    Superb Fixed Field Permanent Magnet Proton Therapy Gantry.Proceedings of IPAC2021(Campinas, Brazil: JACoW Publishing) (2021), 1405–1408

    Trbojevic D, Brooks S, Roser T, Tsoupas N. Superb Fixed Field Permanent Magnet Proton Therapy Gantry.Proceedings of IPAC2021(Campinas, Brazil: JACoW Publishing) (2021), 1405–1408. doi:10.18429/JACoW-IPAC2021-TUPAB030

  157. [168]

    Beam delivery systems for linac-based proton therapy (2021)

    [Dataset] Dascalu TS, Sheehy SL. Beam delivery systems for linac-based proton therapy (2021)

  158. [169]

    Design of a large momentum acceptance proton therapy gantry utilizing AG-CCT magnets.Nuclear Science and Techniques35(2024) 172

    Liao YC, Liu X, Wang W, Yang ZY , Chen QS, Qin B. Design of a large momentum acceptance proton therapy gantry utilizing AG-CCT magnets.Nuclear Science and Techniques35(2024) 172. doi:10.1007/s41365-024-01522-1

  159. [170]

    Design of a large energy acceptance beamline using fixed field accelerator optics.Physical Review Accelerators and Beams27(2024) 071601

    Steinberg AF, Appleby RB, Yap JSL, Sheehy SL. Design of a large energy acceptance beamline using fixed field accelerator optics.Physical Review Accelerators and Beams27(2024) 071601. doi:10.1103/PhysRevAccelBeams.27.071601

  160. [171]

    OPTIMISATION OF A PERMANENT MAGNET MULTI-ENERGY FFA ARC FOR THE CEBAF ENERGY UPGRADE.Proceedings of IPAC2024(Nashville, TN: JACoW Publishing) (2024)

    Brooks SJ. OPTIMISATION OF A PERMANENT MAGNET MULTI-ENERGY FFA ARC FOR THE CEBAF ENERGY UPGRADE.Proceedings of IPAC2024(Nashville, TN: JACoW Publishing) (2024)

  161. [172]

    Permanent magnet resiliency in CEBAF’s radiation environment: LDRD grant status and plans.Proceedings of IPAC2024(Nashville, TN) (2024)

    Bodenstein R, Deitrick K, Gamage B, Hamlette D, Meyers J, Nissen E, et al. Permanent magnet resiliency in CEBAF’s radiation environment: LDRD grant status and plans.Proceedings of IPAC2024(Nashville, TN) (2024). doi:10.18429/JACoW-IPAC2024-THPS58

  162. [173]

    Rotating Gantries Provide Individualized Beam Arrangements for Charged Particle Therapy.Cancers15(2023) 2044

    Chinniah S, Deisher AJ, Herman MG, Johnson JE, Mahajan A, Foote RL. Rotating Gantries Provide Individualized Beam Arrangements for Charged Particle Therapy.Cancers15(2023) 2044. doi:10.3390/cancers15072044

  163. [174]

    Robust Angle Selection in Particle Therapy.Frontiers in Oncology11(2021) 715025

    Zhou Y , Li Y , Kubota Y , Sakai M, Ohno T. Robust Angle Selection in Particle Therapy.Frontiers in Oncology11(2021) 715025. doi:10.3389/fonc.2021.715025

  164. [175]

    The Heidelberg ion therapy center.Radiotherapy and Oncology73(2004) 186–190

    Haberer T, Debus J, Eickhoff H, J¨akel O, Schulz-Ertner D, Weber U. The Heidelberg ion therapy center.Radiotherapy and Oncology73(2004) 186–190. doi:10.1016/S0167-8140(04)80046-X

  165. [176]

    Iwata Y , Fujimoto T, Matsuba S, Fujita T, Sato S, Furukawa T, et al. Recent progress of a superconducting rotating-gantry for carbon-ion radiotherapy.Nuclear Instruments and Methods in Physics Research, Section B: Beam Interactions with Materials and Atoms406(2017) 338–342. d...

  166. [177]

    Thermal characteristics of a helium-free superconducting magnet system for a fast-ramping heavy-ion synchrotron.Cryogenics 126(2022) 103524

    Yang Y , Mizushima K, Matsuba S, Fujimoto T, Noda E, Urata M, et al. Thermal characteristics of a helium-free superconducting magnet system for a fast-ramping heavy-ion synchrotron.Cryogenics 126(2022) 103524. doi:10.1016/j.cryogenics.2022.103524

  167. [178]

    Brouwer L, Caspi S, Edwards K, Godeke A, Hafalia R, Hodgkinson A, et al. Design and test of a curved superconducting dipole magnet for proton therapy.Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment9...

  168. [179]

    HTS/lTS Hybrid High Field Superconducting Magnet Designs for the Proposed 100 TeV Proton Colliders.Proceedings of the 6th Int

    Gupta R, Anerella M, Ghosh A, Kolonko J, Larson D, Rey C, et al. HTS/lTS Hybrid High Field Superconducting Magnet Designs for the Proposed 100 TeV Proton Colliders.Proceedings of the 6th Int. Particle Accelerator Conf.IPAC2015(2015) 3 pages, 1.201 MB. doi:10.18429/ JACOW-IPAC2...

  169. [180]

    A new configuration for a dipole magnet for use in high energy physics applications.Nuclear Instruments and Methods80(1970) 339–341

    Meyer DI, Flasck R. A new configuration for a dipole magnet for use in high energy physics applications.Nuclear Instruments and Methods80(1970) 339–341. doi:10.1016/0029-554X(70) 90784-6. This is a provisional file, not the final typeset article38 Yap et al.Toward Ultra-fast P...

  170. [181]

    Gantries for carbon ions

    Pullia MG, Felcini E, Benedetto E, Dassa L, De Matteis E, Donetti M, et al. Gantries for carbon ions. Health and Technology(2024). doi:10.1007/s12553-024-00870-7

  171. [182]

    Robin DS, Arbelaez D, Caspi S, Sun C, Sessler A, Wan W, et al. Superconducting toroidal combined- function magnet for a compact ion beam cancer therapy gantry.Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated ...

  172. [183]

    Holder DJ. A Compact Superconducting 330 MeV Proton Gantry for Radiotherapy and Computed Tomography A COMPACT SUPERCONDUCTING 330 MeV PROTON GANTRY FOR RADIOTHERAPY AND COMPUTED TOMOGRAPHY*.Proceedings of IPAC2014(2014)

  173. [184]

    TURBO: A novel beam delivery system enabling rapid depth scanning for charged particle therapy.Journal of Physics: Conference Series2420(2023) 012094

    Yap JS, Sheehy SL, Steinberg AF, Norman HX, Appleby RB. TURBO: A novel beam delivery system enabling rapid depth scanning for charged particle therapy.Journal of Physics: Conference Series2420(2023) 012094. doi:10.1088/1742-6596/2420/1/012094

  174. [185]

    Experimental exploration of a mixed helium/carbon beam for online treatment monitoring in carbon ion beam therapy.Physics in Medicine and Biology65(2020) 0–14

    V olz L, Kelleter L, Brons S, Burigo L, Graeff C, Niebuhr NI, et al. Experimental exploration of a mixed helium/carbon beam for online treatment monitoring in carbon ion beam therapy.Physics in Medicine and Biology65(2020) 0–14. doi:10.1088/1361-6560/ab6e52

  175. [186]

    The potential of mixed carbon-helium beams for online treatment verification: A simulation and treatment planning study.Physics in Medicine & Biology(2024)

    Hardt JJ, Pryanichnikov AA, Homolka N, DeJongh EA, DeJongh DF, Cristoforetti R, et al. The potential of mixed carbon-helium beams for online treatment verification: A simulation and treatment planning study.Physics in Medicine & Biology(2024). doi:10.1088/1361-6560/ad46db

  176. [187]

    Mixed particle beam for simultaneous treatment and online range verification in carbon ion therapy: Proof-of-concept study

    Mazzucconi D, Agosteo S, Ferrarini M, Fontana L, Lante V , Pullia M, et al. Mixed particle beam for simultaneous treatment and online range verification in carbon ion therapy: Proof-of-concept study. Medical Physics45(2018) 5234–5243. doi:10.1002/mp.13219

  177. [188]

    ESTRO-EPTN radiation dosimetry guidelines for the acquisition of proton pencil beam modelling data.Physics and Imaging in Radiation Oncology31(2024) 100621

    Gom`a C, Henkner K, J¨akel O, Lorentini S, Magro G, Mirandola A, et al. ESTRO-EPTN radiation dosimetry guidelines for the acquisition of proton pencil beam modelling data.Physics and Imaging in Radiation Oncology31(2024) 100621. doi:10.1016/j.phro.2024.100621

  178. [189]

    Use of treatment log files in spot scanning proton therapy as part of patient-specific quality assurance.Medical Physics40(2013) 021703

    Li H, Sahoo N, Poenisch F, Suzuki K, Li Y , Li X, et al. Use of treatment log files in spot scanning proton therapy as part of patient-specific quality assurance.Medical Physics40(2013) 021703. doi:10.1118/1.4773312

  179. [190]

    Impacts of gantry angle dependent scanning beam properties on proton PBS treatment.Physics in Medicine & Biology62(2016) 344

    Lin Y , Clasie B, Lu HM, Flanz J, Shen T, Jee KW. Impacts of gantry angle dependent scanning beam properties on proton PBS treatment.Physics in Medicine & Biology62(2016) 344. doi:10.1088/ 1361-6560/aa5084

  180. [191]

    Clinical implementation and commissioning of the MedAustron Particle Therapy Accelerator for non-isocentric scanned proton beam treatments.Medical Physics47(2020) 380–392

    Grevillot L, Osorio Moreno J, Letellier V , Dreindl R, Elia A, Fuchs H, et al. Clinical implementation and commissioning of the MedAustron Particle Therapy Accelerator for non-isocentric scanned proton beam treatments.Medical Physics47(2020) 380–392. doi:10.1002/mp.13928

  181. [192]

    The influence of lateral beam profile modifications in scanned proton and carbon ion therapy: A Monte Carlo study.Physics in Medicine and Biology55(2010) 5169–87

    Parodi K, Mairani A, Brons S, Naumann J, Kr¨amer M, Sommerer F, et al. The influence of lateral beam profile modifications in scanned proton and carbon ion therapy: A Monte Carlo study.Physics in Medicine and Biology55(2010) 5169–87. doi:10.1088/0031-9155/55/17/018

  182. [193]

    Adjustment of the lateral and longitudinal size of scanned proton beam spots using a pre-absorber to optimize penumbrae and delivery efficiency.Phys Med Biol55(2010) 7097–7106

    Titt U, Mirkovic D, Sawakuchi GO, Perles LA, Newhauser WD, Taddei PJ, et al. Adjustment of the lateral and longitudinal size of scanned proton beam spots using a pre-absorber to optimize penumbrae and delivery efficiency.Phys Med Biol55(2010) 7097–7106. doi:10.1088/0031-9155/ ...

  183. [194]

    Technical Note: Spot characteristic stability for proton pencil beam scanning a).Medical Physics43(2016) 777–782

    Chen CC, Chang C, Moyers MF, Gao M, Mah D. Technical Note: Spot characteristic stability for proton pencil beam scanning a).Medical Physics43(2016) 777–782. doi:10.1118/1.4939663

  184. [195]

    Dowdell SJ, Clasie B, Depauw N, Metcalfe P, Rosenfeld AB, Kooy HM, et al. Monte Carlo study of the potential reduction in out-of-field dose using a patient-specific aperture in pencil beam scanning Frontiers 39 Yap et al.Toward Ultra-fast PBT Treatments proton therapy.Physics ...

  185. [196]

    Range shifter contribution to neutron exposure of patients undergoing proton pencil beam scanning.Medical Physics(2023) mp.16897

    Romero-Exp´osito M, Liszka M, Christou A, Toma-Dasu I, Dasu A. Range shifter contribution to neutron exposure of patients undergoing proton pencil beam scanning.Medical Physics(2023) mp.16897. doi:10.1002/mp.16897

  186. [197]

    Both S, Shen J, Kirk M, Lin L, Tang S, Alonso-Basanta M, et al. Development and Clinical Implementation of a Universal Bolus to Maintain Spot Size During Delivery of Base of Skull Pencil Beam Scanning Proton Therapy.International Journal of Radiation Oncology*Biology*Physics90...

  187. [198]

    Jelen U, Bubula ME, Ammazzalorso F, Engenhart-Cabillic R, Weber U, Wittig A. Dosimetric impact of reduced nozzle-to-isocenter distance in intensity-modulated proton therapy of intracranial tumors in combined proton-carbon fixed-nozzle treatment facilities.Radiation Oncology8(2...

  188. [199]

    Investigations of line scanning proton therapy with dynamic multi-leaf collimator.Physica Medica55(2018) 47–55

    Kim DH, Park S, Jo K, Cho S, Shin E, Lim DH, et al. Investigations of line scanning proton therapy with dynamic multi-leaf collimator.Physica Medica55(2018) 47–55. doi:10.1016/j.ejmp.2018.10. 009

  189. [200]

    Commissioning of a gantry beamline with rotator at a synchrotron-based ion therapy center.Physical Review Accelerators and Beams27(2024) 023503

    Pivi MTF, Adler L, Guidoboni G, Kowarik G, Kurf¨urst C, Maderb¨ock C, et al. Commissioning of a gantry beamline with rotator at a synchrotron-based ion therapy center.Physical Review Accelerators and Beams27(2024) 023503. doi:10.1103/PhysRevAccelBeams.27.023503

  190. [201]

    Impact of spot size on plan quality of spot scanning proton radiosurgery for peripheral brain lesions.Medical Physics41(2014) 121705

    Wang D, Dirksen B, Hyer DE, Buatti JM, Sheybani A, Dinges E, et al. Impact of spot size on plan quality of spot scanning proton radiosurgery for peripheral brain lesions.Medical Physics41(2014) 121705. doi:10.1118/1.4901260

  191. [202]

    The physics of proton therapy.Physics in Medicine & Biology60(2015)

    Newhauser WD, Zhang R. The physics of proton therapy.Physics in Medicine & Biology60(2015). doi:10.1088/0031-9155/60/8/R155

  192. [203]

    Experimental characterization of two-dimensional pencil beam scanning proton spot profiles.Physics in Medicine and Biology58(2013) 6193–6204

    Lin L, Ainsley CG, McDonough JE. Experimental characterization of two-dimensional pencil beam scanning proton spot profiles.Physics in Medicine and Biology58(2013) 6193–6204. doi:10.1088/0031-9155/58/17/6193

  193. [204]

    Experimental characterization of two-dimensional spot profiles for two proton pencil beam scanning nozzles.Physics in Medicine and Biology59 (2013) 493–504

    Lin L, Ainsley CG, Solberg TD, McDonough JE. Experimental characterization of two-dimensional spot profiles for two proton pencil beam scanning nozzles.Physics in Medicine and Biology59 (2013) 493–504. doi:10.1088/0031-9155/59/2/493

  194. [205]

    Linz U, editor.Ion Beam Therapy: Fundamentals, Technology, Clinical Applications(Springer) (2012)

  195. [206]

    Therapeutic step and shoot proton beam spot-scanning with a multi-leaf collimator: A Monte Carlo study.Radiation Protection Dosimetry115(2005) 164–169

    Bues M, Newhauser WD, Titt U, Smith AR. Therapeutic step and shoot proton beam spot-scanning with a multi-leaf collimator: A Monte Carlo study.Radiation Protection Dosimetry115(2005) 164–169. doi:10.1093/rpd/nci259

  196. [208]

    Rana S, Rosenfeld AB. Impact of errors in spot size and spot position in robustly optimized pencil beam scanning proton-based stereotactic body radiation therapy (SBRT) lung plans.Journal of Applied Clinical Medical Physics22(2021) 147–154. doi:10.1002/acm2.13293

  197. [209]

    Utility of a patient-specific aperture collimator and multi-leaf collimator in line scanning proton therapy.Journal of the Korean Physical Society (2024)

    Ko M, Jeon C, Ahn SH, Han Y , Chung K, Cho S, et al. Utility of a patient-specific aperture collimator and multi-leaf collimator in line scanning proton therapy.Journal of the Korean Physical Society (2024). doi:10.1007/s40042-024-01166-9. This is a provisional file, not the f...

  198. [210]

    Dosimetric impact of spot size variations in proton pencil beam scanning — a Monte Carlo simulation study.Medical Engineering & Physics140 (2025) 104346

    Guo J, Zhang F, Cheng J, Zhou R, Sheng Y . Dosimetric impact of spot size variations in proton pencil beam scanning — a Monte Carlo simulation study.Medical Engineering & Physics140 (2025) 104346. doi:10.1016/j.medengphy.2025.104346

  199. [211]

    Motion interplay as a function of patient parameters and spot size in spot scanning proton therapy for lung cancer

    Grassberger C, Dowdell S, Lomax A, Sharp G, Shackleford J, Choi N, et al. Motion interplay as a function of patient parameters and spot size in spot scanning proton therapy for lung cancer. International Journal of Radiation Oncology Biology Physics86(2013) 380–386. doi:10.101...

  200. [212]

    Safai S, Bortfeld T, Engelsman M. Comparison between the lateral penumbra of a collimated double-scattered beam and uncollimated scanning beam in proton radiotherapy.Physics in Medicine and Biology53(2008) 1729–1750. doi:10.1088/0031-9155/53/6/016

  201. [213]

    What will the medical physics of proton therapy look like 10 yr from now? A personal view.Medical Physics45(2018) e984–e993

    Lomax A. What will the medical physics of proton therapy look like 10 yr from now? A personal view.Medical Physics45(2018) e984–e993. doi:10.1002/mp.13206

  202. [214]

    A patient-specific aperture system with an energy absorber for spot scanning proton beams: Verification for clinical application

    Yasui K, Toshito T, Omachi C, Kibe Y , Hayashi K, Shibata H, et al. A patient-specific aperture system with an energy absorber for spot scanning proton beams: Verification for clinical application. Medical Physics42(2015) 6999–7010. doi:10.1118/1.4935528

  203. [215]

    Characterization of a mini-multileaf collimator in a proton beamline.Medical Physics36(2009) 1886–1894

    Daartz J, Bangert M, Bussi`ere MR, Engelsman M, Kooy HM. Characterization of a mini-multileaf collimator in a proton beamline.Medical Physics36(2009) 1886–1894. doi:10.1118/1.3116382

  204. [216]

    Irradiation System for HIMAC.Journal of Radiation Research48(2007) A15–A25

    Torikoshi M, Minohara S, Kanematsu N, Komori M, Kanazawa M, Noda K, et al. Irradiation System for HIMAC.Journal of Radiation Research48(2007) A15–A25. doi:10.1269/jrr.48.A15

  205. [217]

    A dynamic collimation system for penumbra reduction in spot-scanning proton therapy: Proof of concept.Medical Physics41(2014) 1–9

    Hyer DE, Hill PM, Wang D, Smith BR, Flynn RT. A dynamic collimation system for penumbra reduction in spot-scanning proton therapy: Proof of concept.Medical Physics41(2014) 1–9. doi:10.1118/1.4837155

  206. [218]

    Contour scanning, multi-leaf collimation and the combination thereof for proton pencil beam scanning.Physics in Medicine & Biology64(2018) 015002

    Winterhalter C, Meier G, Oxley D, Weber DC, Lomax AJ, Safai S. Contour scanning, multi-leaf collimation and the combination thereof for proton pencil beam scanning.Physics in Medicine & Biology64(2018) 015002. doi:10.1088/1361-6560/aaf2e8

  207. [219]

    Moignier A, Gelover E, Wang D, Smith B, Flynn R, Kirk M, et al. Theoretical Benefits of Dynamic Collimation in Pencil Beam Scanning Proton Therapy for Brain Tumors: Dosimetric and Radiobiological Metrics.International Journal of Radiation Oncology*Biology*Physics95 (2016) 171–...

  208. [220]

    Improving Head and Neck Cancer Treatments Using Dynamic Collimation in Spot Scanning Proton Therapy.International Journal of Particle Therapy2(2016) 544–554

    Moignier A, Gelover E, Wang D, Smith B, Flynn R, Kirk M, et al. Improving Head and Neck Cancer Treatments Using Dynamic Collimation in Spot Scanning Proton Therapy.International Journal of Particle Therapy2(2016) 544–554. doi:10.14338/IJPT-15-00026.1

  209. [221]

    The LET enhancement of energy-specific collimation in pencil beam scanning proton therapy.Journal of Applied Clinical Medical Physics26(2025) e14477

    Smith BR, Hyer DE. The LET enhancement of energy-specific collimation in pencil beam scanning proton therapy.Journal of Applied Clinical Medical Physics26(2025) e14477. doi:10.1002/acm2. 14477

  210. [222]

    Physical and biological impacts of collimator-scattered protons in spot-scanning proton therapy.Journal of Applied Clinical Medical Physics20(2019) 48–57

    Ueno K, Matsuura T, Hirayama S, Takao S, Ueda H, Matsuo Y , et al. Physical and biological impacts of collimator-scattered protons in spot-scanning proton therapy.Journal of Applied Clinical Medical Physics20(2019) 48–57. doi:10.1002/acm2.12653

  211. [223]

    Measurements of fetal dose with Mevion S250i proton therapy system with HYPERSCAN.Journal of Applied Clinical Medical Physics24(2023) e13957

    Hopfensperger KM, Li X, Paxton A, Sarkar V , Su FCF, Price RG, et al. Measurements of fetal dose with Mevion S250i proton therapy system with HYPERSCAN.Journal of Applied Clinical Medical Physics24(2023) e13957. doi:10.1002/acm2.13957

  212. [224]

    Dosimetric delivery validation of dynamically collimated pencil beam scanning proton therapy.Physics in Medicine & Biology68(2023) 055003

    Nelson NP, Culberson WS, Hyer DE, Geoghegan TJ, Patwardhan KA, Smith BR, et al. Dosimetric delivery validation of dynamically collimated pencil beam scanning proton therapy.Physics in Medicine & Biology68(2023) 055003. doi:10.1088/1361-6560/acb6cd. Frontiers 41 Yap et al.Towar...

  213. [225]

    Innovations and the use of collimators in the delivery of pencil beam scanning proton therapy.International Journal of Particle Therapy8 (2021) 73–83

    Hyer DE, Bennett LC, Geoghegan TJ, Bues M, Smith BR. Innovations and the use of collimators in the delivery of pencil beam scanning proton therapy.International Journal of Particle Therapy8 (2021) 73–83. doi:10.14338/IJPT-20-00039.1

  214. [226]

    Trimmer sequencing time minimization during dynamically collimated proton therapy using a colony of cooperating agents.Physics in Medicine & Biology64(2019) 205025

    Smith BR, Hyer DE, Flynn RT, Hill PM, Culberson WS. Trimmer sequencing time minimization during dynamically collimated proton therapy using a colony of cooperating agents.Physics in Medicine & Biology64(2019) 205025. doi:10.1088/1361-6560/ab416d

  215. [227]

    Shoot-through layers in upright proton arcs unlock advantages in plan quality and range verification.Medical Physics52(2025) e18051

    Engwall E, Mikhalev V , Sundstr¨om J, Marthin O, Wase V . Shoot-through layers in upright proton arcs unlock advantages in plan quality and range verification.Medical Physics52(2025) e18051. doi:10.1002/mp.18051

  216. [228]

    Collimating individual beamlets in pencil beam scanning proton therapy, a dosimetric investigation.Frontiers in Oncology12(2022)

    Holmes J, Shen J, Patel SH, Wong WW, Foote RL, Bues M, et al. Collimating individual beamlets in pencil beam scanning proton therapy, a dosimetric investigation.Frontiers in Oncology12(2022). doi:10.3389/fonc.2022.1031340

  217. [229]

    High-speed proton therapy within a short breath-hold (2025)

    Maradia V , Yue N, Molzahn A, Wang J, Pankuch M, Charyyev S, et al. High-speed proton therapy within a short breath-hold (2025). ArXiv [preprint]. arXiv:2510.06766. Available at: https: //arxiv.org/pdf/2510.06766(Accessed Jan 3, 2026)

  218. [230]

    Implementing dispersion measurement as part of scanning proton therapy commissioning and quality assurance.Physics in Medicine & Biology(2023)

    Tan HQ, Lew KS, Koh CWY , Wibawa A, Yeap PL, Master Z, et al. Implementing dispersion measurement as part of scanning proton therapy commissioning and quality assurance.Physics in Medicine & Biology(2023). doi:10.1088/1361-6560/ad0536

  219. [231]

    AAPM task group 224: Comprehensive proton therapy machine quality assurance.Medical Physics46(2019) e678–e705

    Arjomandy B, Taylor P, Ainsley C, Safai S, Sahoo N, Pankuch M, et al. AAPM task group 224: Comprehensive proton therapy machine quality assurance.Medical Physics46(2019) e678–e705. doi:10.1002/mp.13622

  220. [232]

    Mixed-size spot scanning with a compact large momentum acceptance superconducting (LMA-SC) gantry beamline for proton therapy.Physics in Medicine & Biology69(2024) 115011

    Wang W, Liu X, Liao Y , Zeng Y , Chen Y , Yu B, et al. Mixed-size spot scanning with a compact large momentum acceptance superconducting (LMA-SC) gantry beamline for proton therapy.Physics in Medicine & Biology69(2024) 115011. doi:10.1088/1361-6560/ad45a6

  221. [233]

    Effects of spot size errors in DynamicARC pencil beam scanning proton therapy planning.Physics in Medicine & Biology69(2024) 235008

    Rana S, Rosenfeld AB. Effects of spot size errors in DynamicARC pencil beam scanning proton therapy planning.Physics in Medicine & Biology69(2024) 235008. doi:10.1088/1361-6560/ad8feb

  222. [234]

    Ultra-high dose rate transmission beam proton therapy for conventionally fractionated head and neck cancer: Treatment planning and dose rate distributions.Cancers13(2021) 1–12

    van Marlen P, Dahele M, Folkerts M, Abel E, Slotman BJ, Verbakel W. Ultra-high dose rate transmission beam proton therapy for conventionally fractionated head and neck cancer: Treatment planning and dose rate distributions.Cancers13(2021) 1–12. doi:10.3390/cancers13081859

  223. [235]

    Reducing the lateral dose penumbra in IMPT by incorporating transmission pencil beams.Radiotherapy and Oncology 198(2024) 110388

    Kong W, Huiskes M, Habraken S, Astreinidou E, Rasch C, Heijmen B, et al. Reducing the lateral dose penumbra in IMPT by incorporating transmission pencil beams.Radiotherapy and Oncology 198(2024) 110388. doi:10.1016/j.radonc.2024.110388

  224. [236]

    Single high-energy arc proton therapy with Bragg peak boost (SHARP).Journal of Medical Radiation Sciences(2024) jmrs.769

    Penfold SN, Santos AMC, Penfold M, Shierlaw E, Crain R. Single high-energy arc proton therapy with Bragg peak boost (SHARP).Journal of Medical Radiation Sciences(2024) jmrs.769. doi:10. 1002/jmrs.769

  225. [237]

    Hybrid proton planning combining spread-out Bragg peak beams with transmission beams to shorten field delivery times while maintaining plan quality

    Hyt¨onen R, Vanderstraeten R, Verbakel WFAR. Hybrid proton planning combining spread-out Bragg peak beams with transmission beams to shorten field delivery times while maintaining plan quality. Physics and Imaging in Radiation Oncology35(2025) 100809. doi:10.1016/j.phro.2025.100809

  226. [238]

    Geometry optimisation of graphite energy degrader for proton therapy.Physica Medica76(2020) 227–235

    Oponowicz E, Owen H, Psoroulas S, Meer D. Geometry optimisation of graphite energy degrader for proton therapy.Physica Medica76(2020) 227–235. doi:10.1016/j.ejmp.2020.06.023. This is a provisional file, not the final typeset article42

Pith tools

Reviewed August 3, 2026 · model on record in the stance chip above.